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Introduction. 
        Siddha system of medicine, recognizable among the Dravidian population that prevails in 
South India and is practiced from time immemorial especially in Tamil populated region. 
“Siddhars”, Saints and sages of Tamils developed this exceptional system, believed to be in the 
year of 10000 BC- 7000BC. 
 “Siddham” means “Arivu” or “complete knowledge”.  
 
                
            ºð¼ÓÉ¢ »¡Éõ º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ,  Àì¸õ 31. 
                   96 thathuvas were, including Pancha bootha and three Humoural concepts are the 
fundamental principles of this incomparable system which advocates curative, preventive measures 
and educates systematized lifestyle through natural way. As herbs, metals, minerals, animals and its 
derivatives are the core sources for Siddha medicines; this system endorses safest medical care. 
Siddha is the only system comprising 64 varieties of medicines i.e. 32 classifications of internal 
medicines and 32 classifications of external medicines. 
              According to Siddha, “Unavathi seyal marupadu” (changes in Diet and life style), 
Environmental factors and “Kanma vinai” (congenital/ genetically inherited) are the key factors 
predisposed for the instigation of each disease via disturbing the equilibrium status of the vital forces 
termed Vali, Azhal and Ayyam. Noi nadal (to diagnose the affected disease) and Noi mudal nadal (to 
find out the root cause of the disease) are the crucial approaches employed in Siddha in the process 
of diagnosis therefore permanent remedy is also achievable since the treatment is focused to cure the 
disease and root cause of the disease. “Envagai thervu” is the diagnostic tool followed in Siddha for 
arriving right diagnosis. Vinnavar maruthuvam (Divine method); Manida maruthuvam (Rational 
method); and Asura maruthuvam (Surgical method) are the main streams of Siddha treatments. 
Diseases due to Kanma vinai are treated only with DevMaruthuvam. 
                         While treating the patient, special concentration will be paid on Yakkai (Body 
constitution), Thinai (sort of land where the patient is living) and Paruvakalam (Season) for the 
effectiveness of the treatment.  
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                       Varmam and Thokkanam are exceptional treatment practices existing in Siddha to cure 
Neuro-Muscular-Skeletal diseases. Yoga-Pranayamam-Dhyanam is advised for chronic diseases and 
especially psychosomatic in origin. Siddhars developed Kayakarpam methods mainly for longevity 
with complete freedom from illness and for preventing ageing problems. Siddha not only cures 
physical, mental diseases but also cares social, moral, and spiritual welfare of an individual”. 
                        India is a large country with different cultural and dietary habits, which may produce 
regional differences in frequency and the natural course of peptic ulcer. Early observations showed 
that peptic ulcer was more common among the population of South India than North India. 
              A relatively high frequency of peptic ulcer in South India was attributed to the sloppy diet 
which required little mastication. It was shown that saliva had a buffering capacity and protective 
effect on the production of peptic ulcer. 
             Population surveys and the multicentric study conducted by the Indian Council of Medical 
Research, on the prevalence of peptic ulcer, the lifetime prevalence of peptic ulcer was 0-61% in 
Delhi, 0.69% in Chandigarh, and 0.75% in Chennai  
                The point prevalence of peptic ulcer in India was 4.72% and the lifetime prevalence 
was 11-22%.The prevalence of peptic ulcer increased with age, with a peak prevalence of 
28.8% in the 5th decade of life. 
                 Peptic ulcer was not only related to socio-economic status. Peptic ulcer (Gunmam) is a 
disease have seen commonly among white-collar, coolie’s, farmer, labour, poor, & rich 
  During my under graduate study I come across so many patients suffering from dyspepsia, 
Epigastric pain borborgymes, backpain, vomiting, nausea, &mentaldipperation. With this 
experience I have selected the disease Eri gunmam for the clinical study of dissertation work on the 
basis of siddha concepts on course of the disease, diagnosis treatment, and deietic aspects. A wide 
knowledge of siddha and modern concepts about Aetiology, signs and symptoms. Pathology and 
Bio-chemical mechanisms will be helpful to conduct the study in a useful manner. 
 This dissertation is the completion of the data collected during the course of the study for 3 
years in my post- graduate, department of maruthuvam, govt. siddha medical college, Chennai-106. 
 
    
10 
 
 
 
Aim and Objective 
 
 
 
 
 
 
 
 
 
    
11 
 
AIM AND OBJECT 
AIM 
    The main aim of this study is to do a clinical study in one of the 8 types of 
gunmam known as Eri gunmam with more interest and observation on the 
aetiology. Pathology, diagnosis, complications, and the treatment aspects using a 
time honoured siddha medicines. Such as gunmathichooranam, Musumusukai 
legium. 
      OBJECT 
             To collect and detail the study of various siddha and modern literatures 
dealing with aetiology, signs and symptoms, diagnosis, prognosis, complications, 
diet therapy and treatmental aspects of ERI GUNMAM. 
 To expose the efficiency of siddha’s diagnostic principles. 
 
 To have an idea of the incidence of the disease with reference to sex, age, 
habit, occupation. Income and social habits of the patient. 
 
 To know the extent of the correlation of definition aetiology, classification, 
symptom logy, Investigation, diagnostic methods and line of treatment 
compare with the modern medical system. 
 
 To evaluate the chemical (qualitative & quantitative) properties. 
 
 To evaluate toxicological (acute &sub acute) study. 
 
 To evaluate pharmacological action of the trail drugs. 
 
 To analyse statistical values, and anti microbial studies of all trail drugs. 
 
o Gunmathi choornam, 
 
o Musumusukai legium 
 
  To conduct a clinical trial with the above medicine for Eri Gunmam. 
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SIDDHA ASPECT 
CûWlûT«u EPtáß 
 
ÏZ-àP Øû]YkÕ ùRôiûPVlTô 
Ï±lTôL Ø¥ÙùUuß ùR¬kÕ ùLôiÓ 
AZLô] Au]Yô¡ ùNôpX úLÞ 
AlTú] ùRôiûPÙ ]¥«p úRôu± 
TZ¡]úRôo CûWlûTdÏ ùNpÛ¡u\ 
TiTôL R¥jRùRôÚ ÏZÛdúL Rôu 
C]Uô] Au]Yô¡ Guß úTWôm 
               -ALj§Vo ÏQYôPLm TdLm 221 
úL[Pô CÕ ÑYôN ÏZÛdLlTôp 
ùL¥VôL ©u²«ÚdÏm EiûUTôÚ 
Sô[Pô CRu ¿[m ùNôpX úLÞ 
SXUôL KW¥ Rô²ÚdÏm ùNôuú]u 
Yô[Pô CRu Y¯Vôn Au]m Øtßm 
Y[UôL ùNußúU CûWlûT«p úNokÕ 
úL[Pô úNokÕRôu úRLk Ruû] 
ùLôt\Yú] Y[odÏùUuß ùLôÝûU TôúW  
                    --ALj§Vo ÏQYôPLm TdLm 222  
VAAI (Mouth) 
            Mouth is the first part of the GI tract help in ingestion and chewing of food. 
ANNAVAGI (Oesophagus) 
               Oesophagus is a muscular tube that propels the food in to the stomach.   it ends in the 
stomach region. 
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ùLôÝûUÙs[ CûWlûT«u ®YWeúL[ôn 
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Ï±lTô] CûWlûTRôu ÕÚj§ úTôúX 
YÛYô¡ Yû[kÕúU CÚdÏm TôÚ 
YuûUÙs[ À-Lô vRô]m ¨uß 
TÝYô] DWp Ï¯dÏ ûUVô 
T¬YôL Jh¥úV CÚdÏm TôÚ 
ùR°Yô] NûRLÞm NqÜm úNokÕ 
úRLj§p EiPô¡ CÚdÏm TôÚ 
-ALj§Vo ÏQYôLPm TdLm Gi. 222 
EiPô] CûWlûTdÏ ÕYôWªWiÓ 
EjRUú] CÚdÏRPô Eß§TôÚ 
SiPô] JußRô] Au]Yô¡úVôÓm 
ùNiPôL úNok§ÚdÏm A§úX úLÞ 
ùNVXô] ®ÚjR NqÜ U¥lùTôußiÓ 
LiPô] LTôPUÕ JußiÓ 
L¥Rô] ARu ÏQjûRd áßúYú] 
  - ALj§Vo ÏQYôLPm TdLm Gi. 223 
YERIPAI (Stomach) 
                Stomach is the most dilated part of the digestive tube, and it situated between the end of 
the oesphagus and the beginning of the duodenum. 
                    The stomach is pear shaped sub division of stomach are fundus  body, pyloric antrum, 
pyloric canal and pyloric sphincter (Kabadam) 
 
 
 
 
 
 
 
 
SIDDHA ASPECT 
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GUNMAM :  ÌýÁõ 
Synonym : Gulmam 
Definition: 
 Gunmam is a clinical entity which depresses both body and mind since it is called as 
Gunmam.  
Gunmam is commonly known as Gastro intestinal disorders usually associated with 
abdominal pain before or after food with abdominal signs like Indigestion, Nausea , vomiting Gastric 
eructation, burning sensation in stomch etc. 
ETIOLOGY AND PATHOLOGY: 
In ancient days Siddhars have recorded the following causes for the manifestation of Eri Gunmam 
they are Description in 
 agasthiyar Guru Nadi sasthiram 
"ÌýÁÁÐ  ¾¡¦ÉØôÒõ Å¢ÀÃ¦ÁýÉ¢ø 
Ì¼ø¾É¢§Ä ¸øÖÁ¢¸ ¦¿øÖ ãìÌõ 
þýÉÓ¼ý ÅÂ¢ÚôÀ¢ §º¡¨È º¡÷ó¾ì¸¡ø 
 ÒÕÅÐ Ì¼§Ä¡¼ Á¡Í ÀüÚõ 
«ýÉÁÐ ¦º¡¢ì¸¡Ð Á¡º¢É¡§Ä 
«Ð×ÂÃõ ¯Á¢ãìÌ ¸¢ÕÁ¢ ÒìÌõ 
ÅñÉ Ó¨Äì ÌÂ¢Ä¡§Ä ÌýÁ §Ã¡¸õ 
Á¡º¡üÈ¡ø ÌýÁõ ÅÕÅ¨¸¾¡ý À¡§Ã¡"     
                                                             agasthiyar Guru Nadi sasthiram Page No: 21 
 
             
  ¦ºôÀ¢¼§Å ÐÅ÷ôÀ¡É ¦À¡º¢ôÀ¢É¡Öõ 
ÁöÂ¡É Áí¨¸Ô¼ý Á¡÷ì¸ò¾¡Öõ 
  Å¨¸Â¡É ¸¢ÆíÌÅ¨¸ «Õó¾Ä¡Öõ 
¯öÂ¡É  Á¢ÇÌÅ¨¸ Ô¨ÃôÀ¢É¡Öõ 
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  ¯ÚÀº¢¨Â Â¼ì¸¢Îõ Áó¾ò¾¡Öõ 
¾öÂ¡É ºñ¼¡É §¸¡Àò¾¡Öõ 
  ºÄ¢ôÀ¡Öõ ÌýÁõ ÅóÐ ¾¡ìÌõ À¡§Ã" 
Yugi chinthamani piranool 800-Page No : 65  
Dietetic factors  
a) Improper exercise of yogam and pranayamam . 
b) Tubers which will produce flatulence . 
c)  Prolonged starvation, 
d)  hardly digestible foods. 
e) The frequent intake of hot foods.. 
f) Untimely food.   
g) Unbridled sexual indulgence is considered to be the predisposing factors. 
PSYCHOSOMATIC CAUSES: 
According to        siddha maruthuvanga surukam 
®¯«²p ¿WPd¡p 
®RUô] CÚjÕúWôLm 
Y¯VÓ ÀSNeLs 
Yk§Óm úSjWúWôLm 
AÝ¡Óm £W£p úWôLm 
ARàPu YôReá¥p 
TÝÕPp Ti¦ ÏuUm 
Tt±Óe ÏQØiúP 
                                             £jR UÚjÕYôeL ÑÚdLm T.Gi. 211 
One should not hide his deep sorrow by preventing the tears, such a restricted emotion will 
results in gunmam.  
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In Agasthiyar kanma kandam, agasthiyar has  stated the psycho spritual reasons for Gunmam 
as follows 
 
¿ø§Ä¡¨Ã ÁÉõ §¿¡¸ô ÀÆ¢ò¾ À¡Åõ 
 ¾ý¨ÁÂ¢øÄ¡ À¢ü÷ Òº¢ì¸ ¯ñ¼ À¡Åõ 
      ºñ¼¡Ç ¾òÐÅ§Á ¦ºö¾ À¡Åõ 
 þý¨ÁÂ¢§Ä þôÀ¡Åõ ÅóÐ ÍüÈ¢ 
     «¾É¡§Ä ÌýÁ¦ÁÉ ¦ÅÎò¾ Å¡§È " 
- «¸ò¾¢Â÷ ¸ýÁ ¸¡ñ¼õ - Page No: 16. 
Teasing elders and polite neighbors and taking food in the presence of starved people is probably 
the predominant reasons for the sprouting of the awful diseases by their action and covetous mind in 
the past 
TYPES OF CLASSIFICATION & CLINICAL FEATURES 
Thirumoolar’s View 
Thirumoolar classified gunmam into four types as follows, 
1. Mega Gunmam 
2. Vadha Gunmam 
3. Pitha Gunmam 
4. Iya Gunmam 
1. MEGA GUNMAM 
 ÅÄ¢ì¸¢ýÈ §Á¸Øõ Å¡Ô×í ÜÊÊø 
 ÁÄ¢ì¸¢ ÁÄºÄõ À¨¾Â¡Áü ¸ðÊÎõ 
 þÄ¢ì¸¢ þ¼ôÒÈõ þÂøÀ¡ö ÅÄôÒõ 
 ÅÄ¢ìÌõ ÓÚìÌõ ÅÕïÝ¨Å ÌýÁ§Á 
¾¢ÕãÄ÷ ¸Õì¸¨¼ ¨Åò¾¢Âõ 600 - Page No : 44  
            Thirumoolar’s view on gunmam is combination of  mega with disturbed vayu results in Mega 
Gunmam .  Spasmodic pain in the of left and right side of the abdomen , constipation , etc . 
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2.VATHA GUNMAM 
              
   °Õ§Á ÌõÀ¢Â¢ø ¯ÆýÚ Á¢¸§È¡Ìõ 
   §¸¡Ì§Á ÌòÐõ Ì¼¨Ä ÓüÚ¸¢Îõ 
   Å¡Õ§Á Å¡ò¾¢ø ÅÆí¸¢Â ÌýÁõ 
                                  -¾¢ÕãÄ÷ ¸Õì¸¨¼ ¨Åò¾¢Âõ -  Page No:43    
 Thirumoolar’s view on gunmam is combination of disturbed vatha and vayu results in vatha 
Gunmam. The signs and Symptoms are spasmodic pain in the stomach, piercing pain in the intestine, 
etc. 
3. PITHA GUNMAM  
 " ²üÈ¢É ÌýÁõ ±Øó¾Å¢¾í §¸Ù 
      §À¡üÈ¢Â À¢ò¾Óõ Å¡Ô×õ ¦¾¡ó¾¢ìÌû 
§ºüÈ¢Â «ýÉõ ¦º¡¢ì¸¢ø ÅÄ¢ô§ÀÚõ 
Á¡üÈ¢Â ¿£ÕÈ¢ Å¡ó¾¢Â¡õ À¡Õ§Á. 
               -¾¢ÕãÄ÷ ¸Õì¸¨¼ ¨Åò¾¢Âõ 600-  Page No : 43  
Thirumoolar’s view on gunmam is  combination of disturbed pitha and vayu results in pitha 
Gunmam .  Signs and symptoms are pain in the abdomen after the completion of digestion excessive 
salivation , vomiting etc . 
4. IYA GUNMAM 
 
  ¾Æí¸¢Â «ýÉò¨¾ ºó¾¢ì¸ ´ð¼¡Ð 
ÒÆí¸¢Â «ýÉõ ÒÇ¢ôÒ ¦¸¡Îò§¾È¢ 
   ¯Æí¸¢ ÓÚì¸¢ ¯¼Öõ ÅÄ¢ìÌ§Á 
                -¾¢ÕãÄ÷ ¸Õì¸¨¼ ¨Åò¾¢Âõ 600 -Page No: 44  
 Thirumoolar’s view on gunmam is combination of disturbed Kapha and vayu results in Iya 
Gunmam. Fermentation of the swallowed food, accompanied by spasmedic pain in the abdomen and 
pain in all over the body. 
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   THIRUKANDA MUNIVAR‘S CLASSIFICATION 
Thirukanda Munivar classified gunmam into eight types but he differs from Yugi Munivar  
    They are 
  1 . Vadha Gunmam 
  2.  Pitha Gunmam 
  3 . Kapha  Gunmam 
  4 . Vatha Pitha Gunmam 
  5 . Vatha Kapha Gunmam 
  6 .  Pitha Sethma Gunmam 
  7 . Thrithoda Gunmam 
  8 . Rattha Gunmam 
The Rattha Gunmam is further classified into Rattha Gunmam and Ratha pitta Gunmam 
YUGI MUNI’S CLASSIFICATION 
Yugi Munivar in his siddha clinical medicine has classified Gunma noi into eight types . 
They are 
1 . Vayu Gunmam (or) Payuru Gunmam 
2 . Vatha Gunmam 
3 . Pitha Gunmam 
4 . Sethma Gunmam 
5 . Eri Gunmam 
6 . Vali Gunmam 
7 . Satthi Gunmam 
8 . Sanni Gunmam 
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1. VAYU GUNMAM –signs and symptoms :- 
  "À¡÷ì¸§Å Å¡Ô ÌýÁõ À¸Ãì §¸Ç¡ö 
          ÀÕ¸¢Â§¾¡÷ À¾¡÷ò¾í¸û ¦º¡¢ò¾¢¼¡Ð 
  §¾¡÷ì¸§Å ÂºÉü¾¡ý ¦ºøÄ¾¡Ìõ 
          ÐÕò¾¢ìÌû ¸¡üÈÐ§À¡ø ÅÂ¢ÚÓôÒõ 
  °÷ì¸§Å ÂÊÅÂ¢Ú ¾É¢§Ä ÅóÐ 
           Á¢¸ôÒÃñÎ Å¢øÖô§À¡ø Å¢Ìò¾Ä¡§Á"  
                       -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
Anorexia, indigestion, bloating of the abdomen, like bellows with increased peristalsis and 
rigidity in the lower abdomen with sweating, general debility, drowsiness, etc. 
2. Vatha Gunmam – Signs and symptoms 
" Å¢Õò¾Á¡õ Å¡¾ÌýÁõ Å¢ÇõÀì§¸Ç¡ö 
Á¢¸ò¾¡Û ¿¨¼Ì¨ÈÔõ ÁÄõ Å¢¼¡Ð 
ÅÌò¾Á¡ö ¯¼ø¾¡Ûõ Á¢¸ì ¸ÎìÌõ 
¯Èì¸¡Á¡Î ¾¢Âì¸Á¡õ ÔÆ¨ÄÂ¡Ìõ 
¾Îò¾Á¡ï º¡£ÃÁÐ ¸ÉòÐò§¾¡ýÚõ 
ºí¨¸Â¡õ «ºÉÁ¢¸ò ¾¡Ûï ¦ºøÄ¡ 
À¢Ìò¾Á¡õ ¦ÀÄì§¸¼¡ö ¨¸¸¡ø ´Ôõ 
§À¦º¡É¡ ¿¡ÅÈÙõ ¾¨ÄÒõ §¿¡§Â      
    -  Ô¸¢  ¨Åò¾¢Â º¢ó¾¡Á½¢ -Page No : 66 
Anorexia , constipation , headache, dryness of the tongue , pain all over the body , power 
diminished in the upper and lower extremities , inability to walk , heaviness of the body , general 
debility , restlessness etc . 
3 . PITHA GUNMAM :- Signs and symptoms  
" §¿¡õÀ¢ò¾ ÌýÁò¾¢ý ÑðÀí §¸Ç¡ö 
  ÑÉ¢Áïºû ¿¢Èõ§À¡Ä Ó¸Á¡Ìõ 
Å¡ïºò¾¢ Å¡ó¾¢Ôñ¼¡ö À¢½ÁÚìÌõ 
  ÁÂì¸Á¡ö ¦¿ïÍ¾É¢ü §¸¡¨Æ¸ðÎõ 
  ÍÃõ ¦¿ÕôÀ¡ö ¾¡É¢ÕìÌõ ¨¸¸¡§Ä¡Ôõ 
ÍÎ¦ÅÂ¢ü ¸ñ¼×¼ý ¾¨ÄÔï ÍüÚõ 
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   §À¡ãò¾¢Ãõ º¢Åó¾¢ÕìÌõ ¾¡¸í ¸¡Ûõ 
      Óì¸¢§Â ÁÄõ Å£Æõ ãîÍñ¼¡§Á " 
                                     -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢- Page No : 66 
 Discoloration of the face as yellow , nausea , vomiting , fainting , accumulation of mucous secretion 
in the lungs , dyspnoea , fatigue of the upper and lower extremities , Giddiness increases when 
exposure to sunlight , reddish discoloration of urine , increased thirst , constipation etc . 
4. Sethma Gunmam:- signs and symptoms 
¯ñ¼¡Ìõ Å¡ö¿£÷ ¾¡É¢ ¨ÇôÒñ¼¡Ìõ  
¯¼øÅüÈ¢ ¸Õò¾Æ¢Ô ÓÃò¾¢¨ÃìÌõ  
¦Åñ¼¡Ìõ ¦ÀÄý¦¸Îì¸  ÁºÉó ¾ûÙõ 
 Á¢ì¸¡É ¾¨ÄÂ¡¢ìÌõ ¦ÅÇ¢Õ§ÁÉ¢ 
¦¾¡ñ¼¡Ì ¦¿ïÍ¾É¢ü Ò¨¸îºÖñ¼¡õ 
¾¢Îì¸¢ðÎ ¿Îì¸ÖÁ¡óò §¾¸ü¾¡Öõ 
¾¢ñ¼¡Ìóò ¾¨Ä¦ÂíÌõ À¡ÃÁ¡Ìõ 
º¢§ÄðÎÁ Á¡í ÌýÁ¦Áý§È ¦ºôÀÄ¡§Á 
           -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ - Page No : 67  
Excessive salivation , emaciation ,  bronochospasm , lowered vitality , loss of appetite 
fainting , pallor , cough , sudden rigor of the body , heaviness of the head etc.   
    5 . ERI GUNMAM – Signs and symptoms 
¾¢ÎìÌÁ¡ ±¡¢ÌýÁî ¦ºÂ¨Äì §¸Ç¡ö 
 º¢ÚÅÂ¢üÈ¢ ¦Ä¡¢òÐ§Á Ì¼ø ÌÓÚõ 
±ÎìÌõ Å¡ö ¿£÷ ÍÃìÌõ ¾¨Ä ÅÄ¢ìÌõ 
ÅÂ¢ÚôÒõ ¸¢Ú¸¢Úò§¾ ²ôÀÁ¡Ìõ 
¦ÅÊìÌõ ÁÂ¢÷ ¸¡ø§¾¡Úõ Å¢Â÷¨ÅÂ¡Ìõ 
Á¢¸ô ¦À¡ÕÁ¢ ÅÂ¢Ú ¸Æ¢ó ¾¢¨ÃîºÄ¡Ìõ 
±ÎìÌ§Á Ì¼Ä¢¨ÇìÌõ þÃí¸¡ ¾ýÉõ 
   ±¡¢Ô§Á ¯¼¦ÄíÌ Á¢ÕÁ Ä¡§Á. 
                   -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢-Page No : 67 
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 Burning in the stomach, borborgymes, excessive salivation, headache, bloating, eructation, 
sweating, Anorexia, diarrhoea, etc.   
 
6. Vali Gunmam 
"¾¢Á¢Ã¡¸ ÅÂ¢êÚóò ¾¢¨ÃÔ §ÁÉ¢  
  ¦º¼Ó¨ÄóÐ ¸Õò¾Æ¢Ôï º¢¾Úóò àì¸õ 
ÅÁ¢Ã¡¸ ÅÂ¢È¢¦ÈóÐ Óû§À¡§Ä¡Ìõ 
ÅÕò¾Á¡ ÂºÉ Á¢¸ò ¾¡Ûï ¦ºøÄ¡ 
ÓÁ¢Ã¡¸ Å¢Ä¡Å¾É¢üî ¦º¡Õ¸Ä¡Ìõ 
ÓÐÌ¾ñÎ ÅÄ¢¸¡Û Á¢ÎôÒ §¿¡Å¡õ 
¾¢Á¢Ã¡¸ ¸¡ÂÁÐ ¸ÎòÐì ¸¡Ïõ 
¸ÉºÃÁ¡ö ¦À¡öôÀº¢Ôõ ¸¡Ïó¾§É"                             
             
        -ä¸¢¨Åò¾¢Â º¢ó¾¡Á½¢-Page No : 68 
                    Bloating of the abdomen, wrinkles in the skin, dryness. Confusion, disturbed sleep
 Bosborygmus, piercing pain, loss of appetite, pain in the hypochondrium, and pain in the 
back. 
7.  Sathi Gunmam – Signs and Symptoms 
þÕÁÄ¡ï ºò¾¢ ÌýÁõ Á¢Âø¨Àì §¸¡Ç¡ö 
         ®ÃÖìÌû ¦ÅÇ¢Â¡Ì §Áì¸Á¡Ìõ 
     ¾¢ÕÁÄ¡óò ¾¢Âì¸¦Á¡Î ÁÂì¸Óñ¼¡õ 
          º¢ÚÅÄ¢Ô Óñ¼¡¸¢ Å¡ó¾¢Â¡Ìõ 
     ¦À¡ÕÁÄ¡õ. ¦ÀÄý ¦¸ÎìÌõ ÁÄõ Å¢¼¡Ð 
         §ÀÃ¡É «ì¸¢É¢¾¡ý Á¢¸×ñ¼¡õ 
     ¦ºÕÁÄ¡õ ¿¨¼Ì¨ÈÔõ «Õº¢Â¡Ìõ 
         º¢Ú ¿Ãõ¦Àø Ä¡õÒ¨¼òÐò ¾¢Á¢ÕÁ¡§Á' 
                                      -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ - Page No : 68 
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                      Burning in the right hypochondric region. Fainting, coma, dull pain accompanied By 
vomiting, lowered uitality, Constipation. Increased appetite, distaste, prominence of the veins, etc 
 
8. SANNI GUNMAM :- Signs and symptoms 
 "¦ºôÀÄ¡ï ºýÉ¢ÌýÁî ¦ºÂ¨Äì §¸Ç¡ö 
  ¾¢Âì¸¦Á¡Î ÁÂì¸Á¡ö ÌÇ¢Õñ¼¡Ìõ 
   «ôÀÁ¡õ ÁºÉ Á¢¸ò¾¡Ûï ¦ºøÄ¡ 
  «ÊÅÂ¢üÈ¢ Ä¢ÃîºøÖÁ¡ö Å¡ö ¿£ÕÚõ 
    ¯ôÀÄ¡ö-  
 ¯Å÷ìÌõÅ¡ö ¦¿ïº¾É¢ø Ò¨¸îºÖñ¼¡õ 
     ¦¾ôÀÁ¡ö ãîºÐ×í º¢¨¾ó¦¾ØõÒóò  
     §¾¸¦ÁíÌí ÌÇ¢÷îº¢ÔÁ¡Ìõ À¡§Ã"                       
               -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢.  Page No : 67 
Fainting , coma , chillness of the body , loss of appetite , borborygmus, flatulenec in the 
lower abdomen , excessive salivation , diarrhoea , saltish taste , cough , dyspnoea ,etc  
CLINICAL FEATURES:- 
§ÁÅ¢Â ÌýÁó¾¡ý¦ÉØó¾§¾¡÷ Å¢¾í¸û ¦º¡ø§Å¡õ 
À¡¡¢Â À¢ò¾ò §¾¡Îõ Å¡¾Óõ À¡¢óÐ §º¡¢ø 
Å¡¸¢Â Åññ ¿£Õõ Å¡ó¾¢ÂÁ¡Ìõ À¡§Ã. 
À¡ÃôÀ¡ Å¡Ô Å¡¾õ À¡¢×¼§É À¡ÅýÈí¸¢ø 
ÃÈôÀ¡ ¿¡Ê ¾ý¨É ÅÃñÎ¾¡ý Á¢¸§Å §¿¡Ìõ 
§¸¡ÃôÀ¡ ¦¿ïº¢ü ÌòÐõ Ì¼¨Ä ÓÚì¸¢ì ¦¸¡ñÎ  
Å¡ÃôÀ¡ ÅÄ¢ìÌ ¦Áò¾ Å¡¾Á¡ö ÅÆíÌõ Å¡ö§Å. 
ÅÆí¸¢Â «ôÒ§Å¡Î Å¡¾ ¦Áý§ÈÂ¡ø 
 
                    -«¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ-1500  Page  No: 29 
As per the above poem Agasthiyar says in his Agasthiyar vaidya kaviyam -1500  ‘stated the 
causes and clinical features of ‘Gunma Noi’. 
             Flatulence, abdominal pain , indigestion and distention, vomiting, 
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MUKKUTRA THEORY: 
The siddha concept is that, whatever be the course, attribute to the occurrence of 
“GUNMAM” or any other diseases. The manifestation of the disease is the result of disturbed “ 
Dhoshas” i.e vadha, pitha and kapha. 
 " ¯üÈ§¾¡ ¯¼Ä¢ý ÜÚ 
     ¯ÚôÒ¼ý Å¢ÃÅ¢ ¿¢ýÚ 
ÓüÚ§Á §¿¡ö¸û ±øÄ¡õ 
     ¯¼ø¾É¢ø §¾¡ýÚõ §À¡Ð 
ÀüÚ§Á Å¡¾ À¢ò¾ 
      º¢§ÄüÀÉó ¾ýÉ¢ø µý¨Èô 
   ÀüÈ¢§Â §¾¡ýÚõ ±ýÚ 
      À¸÷ó¾É÷ ÓÉ¢Å÷ ¾¡§Á" 
                   -«¸ò¾¢Â÷ ÌÕ¿¡Ê 235 -  Page No: 13 
Tastes of the foods have great influence over the physiological activity of three dhoshas, 
because the tastes and thiri dhoshas are firmed by the different combination of five elements i.e. 
pancha Boothas The combination of five elements in  Thiri Dhoshas are as follows, 
1. Vadha   (Å¡¾õ)      vali   ÅÇ¢  +   vinn Å¢ñ 
2. pitha   (À¢ò¾õ)       Thee ¾£ 
3. kapham ( ¸Àõ)        Neer  ¿£÷  + Mann  Áñ. 
The elemental combination of tastes are as follows. 
1. Sweet  (þÉ¢ôÒ)    = Áñ + ¿£÷ 
 2.Sour (ÒÇ¢ôÒ )         = Áñ + ¿£ 
 3. Salt  (¯ôÒ)            = ¿£÷ + ¾£ 
4. Bitter  (¨¸ôÒ)                    =  ÅÇ¢  + ¾£  
5. Pungency (¸¡÷ôÒ)      =  ÅÇ¢  + Å¢ñ 
6.  Astrigent  (ÐÅ÷ôÒ)   = Áñ + ÅÇ¢ 
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 For example the taste sweet is the combination of mann and Neer The Dhosha kapha 
possesses the same combination, so it is clear that the excess of sweet will initiate kapha and it can 
be balanced by administering the tastes which consists of the other three boothas. 
ERI-GUNMAM : ±¡¢ÌýÁõ  
¾¢ÎìÌÁ¡ ±¡¢ÌýÁî ¦ºÂ¨Äì §¸Ç¡ö 
 º¢ÚÅÂ¢üÈ¢ ¦Ä¡¢òÐ§Á Ì¼ø ÌÓÚõ 
±ÎìÌõ Å¡ö ¿£÷ ÍÃìÌõ ¾¨Ä ÅÄ¢ìÌõ 
ÅÂ¢ÚôÒõ ¸¢Ú¸¢Úò§¾ ²ôÀÁ¡Ìõ 
¦ÅØìÌõ ÁÂ¢÷ ¸¡ø§¾¡Úõ Å¢Â÷¨ÅÂ¡Ìõ 
Á¢¸ô ¦À¡ÕÁ¢ ÅÂ¢Ú ¸Æ¢ó ¾¢¨ÃîºÄ¡Ìõ 
±ÎìÌ§Á Ì¼Ä¢¨ÇìÌõ þÃí¸¡ ¾ýÉõ 
   ±¡¢Ô§Á ¯¼¦ÄíÌ Á¢ÕÁ Ä¡§Á. 
                   -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢.  Page No : 67  
 Burning pain in the stomach , borborygmus ,excessive salivation , headache , bloating ,   
 giddiness,eructation , sweating and diarrhoea are the common symptoms in Eri Gunmam 
THINAI 
Geographically , the living country has been divided into five distinct physical regions , 
namely :- 
1. Kurinchi –Hilly regions 
2. Mullai- Forest regions 
3. Marutham- Fertile regions 
4. Neithal –Sea regions 
5. Palai- Sandy regions 
Each region has got its own characteristics features which influence the inhabitants, mental 
, physical , economic , occupational and cultural activities . In each regions on the basis of its 
peculiar physical and climatic features some ailments are endemic .  The preventive and curative 
measures for these ailments are stated in the medical literature.  
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KALAM (Seasons) 
With reference to the position of the sun in the orbit, the year is divided into six seasons. 
They are, 
1. Kaar kalam – Avanai and Purattasi (August & Septemper) 
2. Koothir Kalam –Ippasi and Karthigai (October & November) 
3. Munpani Kalam – Markazhi and Thai (December & January) 
4. Pinpani Kalam – Masi and Panguni (February & March)      
5. Elavein Kalam – Chithirai and Vaigasi (April & May) 
6. Muduvenir Kalam – Aani and Aadi (June & July). 
 
In every season there will be changes in the land , water , plants , animals and human beings , 
which will modify the physiology and making (rendreing) them susceptible to certain specific 
disease which are common in these seasons . The siddhars have been anticipated those changes and 
advised certain measures in the form of diet, purgative exercises , etc , to avoid the onset of such 
ailment . 
Uyir Thathu: 
 Knowledge of three Uyir thathus and seven Udal Kattugal will be helpful to do detailed study 
on the disease.   
Vatham: 
        It is the life manifestation of Vayu and Ahya boothams.  It is mathirai alavu is -1. 
Location of Vatham: 
 Vatham located in the abanan, faces, idakalai, spermatic cord, Pelvic bone, skin, nerves, 
joints, hairs and muscles. 
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FUNCTIONS OF VATHAM: 
Types of Vatham: It has 10 types; 
1. Pranan  (Uyir Kaal) 
 It is responsible for respiration and deigestion.  But in EriGunmam some of patients 
affected causes Indigestion. 
2.  Abanan (Keezhnokku Kaal) 
 It lies below the umbilicus responsible for the downward expulsion of stools, urine and 
constriction of anal sptincles.  But in Eri Gunmam some of patients affected causes Diarrhoea 
and some patients have constipation. 
3. Viyanan (Paruva Kaal) 
 It is responsible for the action of all organs, sensation and absorption of food.  But in Eri 
Gunmam some patients affected causes malabsorption. 
4. Uthanan (Melnokku Kaal) 
 It is responsible for the absorption and distribution of food.  In but in Eri Gunmam some of 
patients affected causes malabsorption, Nausea, vomiting. 
5. Samanan (Nadu Kaal) 
 It is responsible for the balancing of the vayus: absorption of nutrition’s and water balance of 
the body.  But in Erigunmam some of patients affected causes indigestion and 
malabsorption. 
6. Nagan. 
 It is responsible for the movements for eyelids. 
7. Koorman: 
 It is responsible for the sight, closing of eyelids, yawning and closure of mouth. 
8. Kirukaran: 
 It is responsible for the secretion of mouth and nose, appetite, sneezing, cough.  In 
Erigunmam some of patients affected lose of apetite. 
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9. Devathathan: 
 It is responsible for aggravating of the emotional disturbances anger,etc. some of patients 
affected causes stress and strain. 
10. Thanajayan: 
 It escapes from the head on the third day after death. 
Pitham: 
 It is the life manifestation of the bootham. It’s mathirai is ½.  
 Location of Pitham in the body: 
 Pitham is located in Pirana Vayu,  blood, Moolakini, heart, Umbilkal region, abdomen, 
sweating, saliva, eyes and skin. 
Functions of Pitham: 
 Pitham controls digestion, temperature, vision, appetite, thirst, taste and strength of the body.  
It is responsible for the formation of red or yellow colour in the body and heat especially during 
digestion.  It is also responsible for giddiness, increase of blood, discolouration of stools, urine, 
anger, memory and bitter and sour taste. 
1. Anala Pitham  
 Its action is characteristic of thee.  This is responsible for digestion of food. In Eri Gunmam 
some of patients affected causes like indigestion. 
2. Ranjaga Pitham  
 It is responsible for the colour and contents of the blood. 
 In Eri Gunmam some patients affected causes like anaemia. 
3. Saathagam  
 It lies in the heart.  It is responsible for the action after thinking. 
 In Erigunman it is affected causing inability to do work properly. 
4. Prasagam  
 It is responsible for the complexion of skin.  
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5. Aalosagam  
 It is responsible for the vision. 
 Some patients affected causes defective vision. 
Kapham: 
 It is the life manifestation of mann and Neer.  It is mathirai’s is ¼. 
Location of Kapham: 
 Kapham is located in Samana Vayu, Sperm, head, tongue, vulva, fat, bone marrow, blood, 
nose, chest, nerve, bone brain, eyes and joint and it provides the material for the structure of every 
cell of the body. 
Functions of Kapham: 
 Generally it acts as a distructive factor in the body.  When Kapham is in normal condition, it 
maintains heart function, taste, coolness of eyes, lubricates and aids free movements of the joints. 
1. Avalambagam 
It causes diseases of the respiratory system when it is affected thereby indirectly affecting 
the other Iyyams. 
2. Kilethagam  
 Appetite and digestion may not be normal when it is affected. 
 In Erigunmam some patients affected causing indigestion and loss of apetite. 
3. Pothagam 
 It is present in the tongue and gives and taste. 
 Some patients affected causes like anorexia. 
4. Tharpagam  
 Memory and perception of senses may be affected when this is deranged. 
5. Sandhigam  
 It is present in the joints and helps free movements. 
 Some patients have mobility of joints is affected due to drying up of the synovial fluid.  
    
32 
 
SEVEN UDAL KATTUGAL: 
 There are seven primary body tissues which constitute the entire human body and all the 
organs of the various systems. 
1. Saaram: 
 It is the end product of digestive process. It gives strength to the body and mind. 
 It is affected in all patients.  They have indigestion. 
2. Seneer: 
 The saram after absorption is converted into seneer.  It is responsible for knowledge, strength 
and health complexion.  
 In Eri Gunmam all patients have malabsorption. 
3. Oon: 
 It gives figure and shape to the body.  It is responsible for the movement of the body. 
 In Eri Gunmam some patients have loss of weight. 
4. Kozhuyppu 
 It lubricates the organs and thus facilitates their function. 
5. Enbu: 
 Gives shape to the body helps locomotion and protects vital organs. 
6. Moolai  / Machai 
 Present in the bone and it gives strength, maintains the normal condition of the bone. 
7. Sukkilam / Suronitham: 
 Responsible for reproduction. 
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PINIYARI MURAIMAI: 
 The method adopted to find out a disease in Siddha is known as PINIYARI MURAIMAI.  It 
is based on the following principles. 
 Poriyal Arithal 
 Pulanaal Therthal 
 Vinavuthal 
“Pori” is the five organs of perception namely Nose, Tongue, Eyes, Ears and skin.  “Pulan” is 
the five objects of senses smell.  Taste, vision auditory and sensation respectively corresponding to 
“Pori”.  Proiyalarithal and Pulanal Therthal go hand in hand with the concept to examining the 
patients “Pori” and “Pulan” with that of the “Patient’s.  Pori and Physicians Pulan”. 
“Vinathal” is a method of inquiring the details of either the patients problem that made him to 
approach the physician from his own or his/her attendants who accompany them. 
Along with, above mentioned principles is also carried out inspection in modern medicine.  
Besides, Thottuparthal (Palpation) and Thattiparthal (Percussion) are also used to diagnose a patient. 
The Primi method adopted to diagnosic the disease is by means of “Envagai Thervugal” 
(Eight types of investigation), Envagai Thervugal of Physician instruments and can be understood by 
the following versus. 
“eho¥ gçr« eh ãw« bkhê éê 
  Ky« _¤Âu« äit kUªJtuhÍj«” 
                   - njiua® Á¤j kU¤Jt nehŒehlš nehŒKjš ehlš Âu£L   ghf« -1   
                                                                                                                           g.v©.270 
Envagai Thervugal Constitute: 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
5. Sparism 
6. Malam 
7. Moothiram 
8. Naadi 
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1. Naa: 
 The colour character and condition of the tongue change according to the changes of 
Mukkutram. 
 In Eri Gunmam some patients have pallor tongue and some patients have coated tongue. 
2. Niram  
 Signs of Vatha, Pitha, Kaba, colours, mixed colour cyanosis, Pallor, flusing or yellowish 
discolouration can be studies by means of Niram. 
 In Eri Gunmam some patients have pallor skin due to anaemia.  
3. Mozhi  
 Constitues high or low pitched voice, slurring and incoherent speech, nasal or crying, 
hoarseness of voice etc. 
4. Vizhi   
 Along with sight, anatomical lesions are noted.  Burning of the eyes, lacrimation, irritation 
colour change of the eyes also noted. 
5. Sparism  
 By palpation and inspection, the following informtion’s were elicited.  Temperature of the 
skin, whether uniformly hot or cold, thickness, fissures stuff / hard swelling, wrinkles, pigmentation 
of hairs etc. 
6. Malam  
 Vatha Type :  Hard, rough, dry, scanty and black 
 Pitha type   :  loose stools with yellow colour, moderate in quantity 
 Kapha type :  gray or white coloured stools, huge in quantity with Slimy, mucus and 
frothy bubbles. 
In Erigunmam some of them have Diarrhoea, and some patients have constipation. 
7. Moothiram  
Colour , quantity , froth , thickness , odour , frequency , retention or obstruction signs. 
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8. Naadi:  
Naadi is responsible for the existence of life can be felt one inch below the wrist on the 
radical side by means of palpation with the tips of index , middle and ring finger , Corresponding to 
vatham , pitham , Kapham  
Three humors vatham, pitham, kabam exists in the ratios 1:1/2:1/4 normally. De arrangement 
in these ratios leads to various diseases entities.  
 
DIFFERENTIAL DIAGNOSIS 
  Gunmam should be differentiated from the following chronie diseases of the Gastro 
intestinal tract which resembles Gunmam. 
 
 GUNMA SOOLAI 
  Yugi Munivar Stated in his work 
         ¾¡ûÙ ÌýÁî Ý¨Ä¾¨Éî ¦º¡øÄì §¸Ç¡ö 
¾ÇÕõ ãò¾¢Ãïº¢ì¸Ä¡¸¢     
ÅûÙÅÂ¢ü ¦À¡ÕÁ¢ ºò¾¢Â¨Ãîºø ã÷î¨º   
ÅÄ¢ò¦¾¡¢òÐî Ý¨Ä§À¡ø ÅÂ¢üÈ¢ü §¿¡ýÈ¢ 
¦¾ûÙÅ¡ö ¿£ÕÈ §ÄôÀ ãñ¼¡õ 
  º¢ÚòÐ§Á «ºÉÁ¢¸ ¦ÅÐõÀÄ¡¸¢ 
«ûÙ§Á Âí¸¦ÁÄ¡ ÁÆüº¢Â¡Ìõ 
              -
ä¸¢ º¢ó¾¡Á½¢-800- Page No : 71 
 
 
Constipation, retention of wine, bloating of the abdomen, borborgymes accompanied by vomiting, 
stabbing pain in the abdomen excessive salivation, gastric evacuation, general emaciation, lower 
fever, dryness of the body. 
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VAYITRU SOOLAI (OR) AMA SOOLAI 
 Yugi munivar described Ama soolai in his work Yugi chinthamani as follows. 
ÀÃ×§Á ¬ÁÝ¨ÄÂ¢ý Ì½óò¾¡ý 
À¡Å¡É «º£Ã½ò¾¢ý ÀñÀ¢½¡Öü 
¾¡×§Á ¾ñ½£÷¾¡ý ÌÊò¾Ä¡Öü 
¾Ìó¾ ÒÇ¢ôÒ ¸ºôÒò ¾¢ò¾¢ôÀ¡Öõ 
°×§Á ¯ÀÅ¡ºõ Àñ½Ä¡Öõ 
¯È ÅÇ÷ó¾ Áó¾¦Á¡Î º£¾ò¾¡Öõ 
 Å¡×§Á ÅÂ¢§È¡Î Å¢Ä¡ô Àì¸í¸û 
ÅÄ¢òÐ§Á ¸ÎôÒÁ¢¸ì ÌòÐñ¼¡§Á 
                                -ä¸¢ º¢ó¾¡Á½¢-800 -  Page No : 71 
                  Indigestion intake of impure water intake of food which are excessive in sour. Bitter and 
sweet tastes and frequent Starvation the seetham in the Stomach is Vitiated. The vitiated seetham 
causes dullness in the secretary and modility functions in the stomach. The Vitalized Vatha disturbed 
the physiological functions of samanakkini and samanavaya as a result of which manifest the pain in 
the abdomen and the hypochondriam. The pain is pricking in character. 
DIAGNOSIS:- 
Final diagnosis is made on the basis of the points discussed under the heading clinical 
features , investigation and the pulse reading of any one of the provocation of Mukkutram . Which 
are the confirmative signs of the disease “Eri Gunmam”. 
Treatment of disease: 
 After the Thiridoshas are brought down to its equilibrium sate, the signs and symptoms of 
disease should be treated properly.  
 For this study.  
1. Gunmathi Choornam – 1 g  3 times / day with Hot water / milk, After Food. 
2.   Musumusukai Lehyam -  5 gm 2 times / day after food. 
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Diet: 
 As irregular diet is the main etiological factor for Gunman all the patients were chiefly 
advised to have their food in time. 
 They are advised to have well cooked cereals, green leafy vegetables pulses and rice. 
 They are advised to get rid of spicy, tubers, food roughage diet, semi cooked and unhygienic 
diet 
  patients were advised to avoid non vegetarian diet. 
 
Habits: 
 Patients were advised to get rid of smoking, alcohol, etc. 
            advised to have timely diet. 
SPECIAL MEDICINE :- 
Yoga Therapy in the treatment of Eri Gunmam 
 Yoga is a system of siddha philosophy that requires .  Intense Mental and physical 
discipline as a means of attaining union with the unique spirit . 
 A system of physical exercise and position used in Yoga . 
 A Yogi under guidance of a Guru only goes through eight stages at training as the 
way to motcha . 
 The Yogi taught disciplines and behaviours called Iyama . 
 The Yogi taught self purification called Niyama . 
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The following yoga’s are of beneficial effects in the treatment of Gunmam 
             Virabadrasana                             Uradva Prasarita padasana 
 
 
 
 
 
Jathara Parvarthasana                                 Savasana 
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Modern Aspect 
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G I TRACT 
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ASPECTS OF MODERN MEDICINE 
STOMACH 
Anatomy 
                     The word stomach is derived from the Latin stomachus which is derived from the Greek 
word stomachos, ultimately from stoma  "mouth". The words gastro- and gastric (meaning related to 
the stomach) are both derived from the Greek word gaster). 
                     The stomach lies between the oesophagus and the duodenum (the first part of the small 
intestine). It is on the left upper part of the abdominal cavity. The top of the stomach lies against the 
diaphragm. Lying behind the stomach is the pancreas. The greater omentum hangs down from the 
greater curvature. 
sphincters 
                    Two sphincters keep the contents of the stomach contained. They are the esophageal 
sphincter (found in the cardiac region, not an anatomical sphincter) dividing the tract above, and the 
Pyloric sphincter dividing the stomach from the small intestine. 
                   The stomach is surrounded by parasympathetic (stimulant) and orthosympathetic 
(inhibitor) plexuses (networks of blood vessels and nerves in the anterior gastric, posterior, superior 
and inferior, celiac and mysenteric), which regulate both the secretions activity and the motor 
(motion) activity of its muscles. 
                    In adult, the stomach has a relaxed, near empty volume of about 45 ml. Because it is a 
distensible organ, it normally expands to hold about one litre of food,[4] but can hold as much as two 
to three litres. The stomach of a newborn baby will only be able to retain about 30 ml. 
                    The stomach is divided into four sections, each of which has different cells and 
functions.  
The sections are: 
Cardia 
Where the contents of the oesophagus empty into the stomach. 
 
    
42 
 
Fundus 
Formed by the upper curvature of the organ. 
Body or Corpus 
The main, central region. 
Pylors 
The lower section of the organ that facilitates emptying the contents into the small intestine. 
Peritoneal folds attached to stomach 
 Gastro phernic ligaments, gastro splenic omentum, greutes omentum and lesser omentum, 
parasympathetic fibres reach through the gastric nerves.  The anterior gastric nerve, the branch of the 
left vagus descends to the anterior surface of stomach close to the lesser curvature.  The posterior 
gastric nerve a branch of right vagus runs close to the lesser curvature on the posterior surface of 
stomach. 
               Like the other parts of the gastrointestinal tract, the stomach walls are made of the 
following layers, from inside to outside 
Mucosa 
               The first main layer. This consists of the epithelium and the lamina propria (composed of 
loose connective tissue), with a thin layer of smooth muscle called the muscularis mucosae 
separating it from the submucosa beneath. 
sub mucosa 
               This layer lies over the mucosa and consists of fibrous connective tissue, separating the 
mucosa from the next layer. The Meissen’s plexus is in this layer. 
                Over the sub mucosa, the muscular is external in the stomach differs from that of other GI 
organs in that it has three layers of smooth muscle instead of two. 
Inner oblique layer: This layer is responsible for creating the motion that churns and physically 
breaks down the food. It is the only layer of the three which is not seen in other parts of the digestive 
system. The antrum has thicker skin cells in its walls and performs more forceful contractions than 
the fundus. 
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Middle circular layer: At this layer, the pylorus is surrounded by a thick circular muscular wall 
which is normally tonically constricted forming a functional (if not anatomically discrete) pyloric 
sphincter, which controls the movement of chyme into the duodenum. This layer is concentric to the 
longitudinal axis of the stomach. 
Outer longitudinal layer: Auerbach's plexus is found between this layer and the middle circular layer. 
Serosa 
                        This layer is over the muscular is externa, consisting of layers of connective tissue 
continuous with the peritoneum. 
Blood supply 
  left and right gastric artery,  
  left and right gastroepiploic artery  
  short gastric artery.  
            The lesser curvature of the stomach is supplied by the right gastric artery inferiorly, and the 
left gastric artery superiorly, which also supplies the cardiac region. The greater curvature is supplied 
by the right gastroepiploic artery inferiorly and the left gastroepiploic artery superiorly. The fundus 
of the stomach, and also the upper portion of the greater curvature, are supplied by the short gastric 
artery. 
Like the other parts of the gastrointestinal tract, the stomach walls are made of the following layers, 
from inside to outside: 
NERVES SUPPLY 
             The anterior gastric nerve, the branch of the left vagus descends to the anterior surface of 
stomach close to the lesser curvature.  The posterior gastric nerve a branch of right vagus runs close 
to the lesser curvature on the posterior surface of stomach. 
 The sympathetic nerves are  a) Vasomotor,  b) Motor to pyloric sphincter, but inhibitory to 
the other parts of the gastric musculature and c) main pathway for main impulses from the stomach. 
 Parasympathetic supply to stomach are (posterior gastric nerve).  Right vagus  (2) Coeliac 
branch (Gastric Branches). 
 
Applied Anatomy: 
 The gastric ulcers are common in the lesser curvature but more in the pyloric region.  
    
44 
 
 
a)   Vessels to the pyloric end of the stomach carry less blood compared to their size, since 
they are branches of the hepatic than to the left gastric and they branch to the stomach from the 
splenic.  The difference in the blood supply as regarded as one of the factors responsible for the 
occurrence of larger percentage of gastric ulcers towards the pyloric end of the mucosa.  
 
b) There is no sub mucosal plexus.  The occurrence of this type i.e. direct from the sub-
serous vessels apparently increases from cardiac to the pyloric regions in man.  Increased vagal tone 
can produce marked constriction of the mucosal vessels of this region causing ischemia and necrosis.  
c) Further musculature of the pyloric end is thicker and more powerful. 
 
d) Anterior-venous anastomoses occurs in the gastro-duodena mucosa and dysfunctions 
are these might lead to local ischemia and ulcer formation. 
 
 A chronic gastric ulcer usually occurs in alkaline producing mucosa i.e. pyloric antral mucosa 
closer to the lesser curvature.   The secretion of acid and pepsin is by the mucosa of the body and to a 
lesser extent, the fundus and it is controlled by  a) vagus and b) the hormone gastric produced by the 
antral mucosa.  For treatment of chronic gastric ulcer the acid secretions are reduced by a) the section 
of the vagus nerve and b) by removing the gustrin producing pyloric and run.  
 
 A chronic ulcer can perforate through the anterior wall of stomach into the greatest sac 
producing diffuse peritonitis.  If the ulcer perforates the posterior gastric wall, it open into lesser sac 
and may erode the pancreas to produce severe back pain or bleeding of the splendid artery.  Pain 
from the stomach is referred to the epigastrium.  The afferent pain impulses pass through the 
sympathetic the coeliac ganglia and reach the spinal cord through the greatest splanchnic nerve. 
 
 The interior of the stomach can be viewed directly or mucosal biopsy can be done through an 
Endoscope.  Endoscope’s purpose is to differentiate between gastric or duodenal ulcer and cancer of 
the stomach through HPE. 
 
Duodenum: 
 Duodenum is the most fixed part of the small intestine.  It extends from the pyloroduodenal 
junction,  2.5 cm to the right of the midline on the transpyloric  plane to the duodeno jejuna flexure 
situated on the left side of the second lumbar  vertebra.  
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Situation and Shape: 
 It is situated on the posterior abdominal wall and is in the form of letters ‘C’ the concavity of 
its curvature is directed upwards and to the left. 
 
Measurements: 
 Its length is 25cm and width is about 3.75 cm. it is the widest part of the small intestine. 
 
RADIOLOGICAL ANATOMY: 
 
 The alimentary tract can be demonstrated  radiologically  by giving barium meal a watery 
suspension of barium sulphate and taking X-ray pictures at regular intervals.  The fundus of the 
stomach, the lesser and greater curvature and the incisura angularis can be easily made out. 
 
 The barium meal passes into the first part of the duodenum and forms a homogenous 
triangular shadow called the duodena’ cap, its base being  directed towards the pylorus.  The 
duodenal cap shadow is smooth due to the absence of mucous fold.  Persistent deformity of the 
duodenal cap is characteristic of duodenal ulcer. 
  
 
Physiology of the Alimentary Tract: 
 The alimentary tract is a co-ordinated structure with the function of ingesting and absorbing 
nutrients and excreting unabsorbed waste products.  It should not be regarded as a series of separate 
organs.  Since the role of each component is closely related to that of other parts of the tract.  Its 
operation may be considered under the following heading. 
1.Motility: 
 Apart from the striated muscle in the upper oesophages, smooth muscle is responsible for the 
motility of the gastrointestinal tract.  The smooth muscle produces ‘slow waves’ which are 
conducted over long distances.  These do not result in contraction but they enable contractions in 
different areas to be co-ordinated. 
2.  Defence Mechanisms: 
 These are necessary to protect the mucosa from its own digestive enzymes and from the 
bacterial population to which it is exposed.  These mechanisms include a rapid turnover of the 
epithelial cells, the production of mucous and a specialized immunological system. 
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3.  The controlling and Co-ordinating Mechanisms: 
 The cells of the gastrointestinal tract are controlled by the transmission of chemical 
messenger which are amino acids or their derivatives, amines or peptides.  The transmission of the 
message is called neuro crine when it is across a synapse, when it is through the intercellular space it 
is called as pericrania and when it is via the blood it is called as endocrine.  Many harmones and 
peptides have now been discovered.  Each being produced by a distinctive cell type in the gastro 
intestinal mucosa of pancreas peptide hormones or pericrania substances are released in response to 
the food in the upper gastrointestinal truct, their function being to control the progression of nutrients 
by modifying nervous stimuli, and to stimulate of inhibit, secretions at the appropriate time.  It is 
now recognized that each even is influenced by a multitude of nervous and hormonal stimuli.  For 
example, the secretion of acid by the stomach is produced mainly by vagal stimuli and the release of 
gastrin, but many other enteric hormones probably have smaller roles to play. 
4.   Secretion: 
 The secretion of enzymes and detergents  enables protein, carbohydrate and fat to be 
digested before absorption.  The secretion of electrolytes provides the correct PH for each stage of 
digestion. 
5.Absorption: 
 The absorptive system consists of specialized cells, together with the portal venous system 
and lymphatics. 
 Small Intestine: 
 Here the co-ordination is due to the slow wave in the longitudinal muscle fibres. It is the 
pacemaker which dictates the times at which any given segment of the gut can contract.  The 
frequency of the slow wave in the duodenum is greater than in the ileum, thus enabling the prominal 
bowel to override more distal areas. 
1. Secretion: 
 The production of secretions for the digestion of nutrients is under nervous and hormonal 
control. 
2. Gastric Secretion: 
 In response to the sight or smell of food, the vagus stimulate acid and pepsin secretion by a 
direct effect on the parietal and peptic cells.  It also initiates the release of gastrin from the antrum.  
More sustained output of this hormone is produced by a rise in PH and by ingested protein.  Gastrin 
then enters the blood stream and acts on the body of the stomach to produce acid and pepsin to digest 
the protein.  It stimulates acid secretion through the release of histamine.  Some mechanisms are also 
involved to turn off gastric secretion, once digestion within the stomach is complex.  They are 
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largely the same as those which slow gastric emptying i.e.  The release of the enteric hormones, 
secretin and cholecystokinin, and also the presence of a low PH in the gastric antrum which inhibits 
the further release gastrin. 
3.  Pancreatic Secretin: 
 Bile and intestinal secretins, acid, fat and hypertonic solutions in the duodenum release the 
hormones secretin and cholecystokinin from the duodenal mucosa into the blood stream.  Secretin 
stimulates the acinar cells of the pancreas to produce bio carbonate which neutralizes the gastric acid 
and provides a neutral PH for the activation  of the pancreatic enzyme lipase, amylase, and trypsin.  
They are produced in response to cholecystokinin, which causes contraction of the gall bladder so 
that an adequate supply of bile acids reaches the intestine when fat has to be digested the enteric 
hormones are responsible for the secretion of succus entericus by the mucosa of the small intestine, 
which contains bicarbonate and additional enzymes. 
4.  The absorptive system: 
 The area the absorption in the small intestine is increased several hundred fold by the 
presence of villi and microvilli.  The surface of the individual cells are made of microvilli which 
passes a multitude of enzyme systems for the final stage of digestion of nutrients followed by their 
absorption.  In celiac disease and topica sprue and the surface area of the small intestine is reduced 
because of the atrophy or loss of villi, and malabsorption results. 
5.  Defence Mechanisms: 
 Cell Turn over: 
 The epithelial cells of the gastrointestinal tract are constantly renewed. for example, the 
epithelial surface of the small intestine is replaced for every 48 hours.  The desquamated cells are 
digested and their products are reabsorbed.  In the intestine, cellular turnover has been shown to be 
slower, than in normal germ free animals and it can be argued that this turnover to some extent 
provides protective mechanism. 
Production of Mucous: 
 Mucous producing cells are present throughout the gastro intestinal tract and mucous has a 
protective function.  In the stomach, the mucous layer on the surface of the epithelium contains 
bicarbonate ions which form part of the barrier to gastric acid. 
Immunological system: 
 The lamina propria of the stomach and the intestine contains many lymphocytes and plasma 
cells.  Some of these cells sysnthesise secretary Ig A which is resistant to digestion by intestinal 
enzyme and has a role in protecting mucosal surface from bacterial invasion.  It is thus of particular 
importance in the small intestine where bacterial colonization is deleterious.   
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THE SYMPTOMS OF ALIMENTARY DISEASE: 
 Pain is often the most important symptom of gastrointestinal disease.  It must be analysed in 
relation to its main site, radiation character, severity, duration, frequency, time of occurrence, 
aggravating and relieving factors and any associated phenomena.  The characteristics of abdominal 
pain are often diagnostic for example in peptic ulceration and acute appendicitis. 
1. Heartburn  
   Burning retrosternal sensation due to reflex esophagitis.  
2. Water brash 
 The sudden filling of the mouth with Saliva which is produced as a reflex response to a variety of 
symptoms from the upper gastrointestinal tract, e.g. peptic ulcer pain. 
3. Vomiting  
 May occur in diseases of the stomach or intestine.  Vomiting of large quantities of food and 
secretions late in the day or night indicates gastric outlet obstruction.  Vomiting which relieves pain 
is often due to a peptic ulcer. 
4. Loss of appetite  
  May be a local cause such as carcinoma of the stomach, but may also be a feature of any 
debilitating disease or due to psychological disturbance. 
5. Regurgitation 
 Appearance of previously swallowed food in the mouth without vomiting.  It usually has an acid or 
bitter taste because of the presence of gastric juice or bile but not in patients with obstruction in the 
oesphagus. 
6. Dysphasia 
 Difficulty in swelling. 
7. Flatulence 
 Due to excessive swallowing of air (aerophagy) which in turn may be due to anxiety under normal 
circumstance a small amount air may be expelled as a belch.  The remainder passes into the intestine.  
Some will be absorbed but most, particularly the nitrogen will be expelled per rectum. 
8. Constipation and Diarrhoea  
 Sometimes difficult to define. 
9. Loss of weight 
 May be due to a reduced intake of food because of anorexia nausea or vomiting to malabsorption of 
nutsients or to the loss of protein from a diseased bowel as in ulcerative colitis carcinoma is the most 
important alimentary cause of loss of weight. 
10. Anemia  
Usually occur in massive hemorrhage or in a non-observed passage of tarry stools.   
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PEPTIC ULCER 
Definition: 
The English word "peptic" comes from the Latin word pepticus which comes from the Greek word 
peptikus which comes from the Greek word peptein, meaning "to digest".  
The English word "ulcer" comes from the Latin word ulcus (genitive: ulceris), meaning "a sore, a 
wound, an ulcer".  
 
 The term ‘Peptic Ulcer’ refers to an ulcer in the lower oesophagus, stomach or duodenum, in 
the jejunum after surgical anastomosis to the stomach.  Or rarely in the ileum adjacent to a Meckel’s 
diverticulum, ulcers in the stomach or deuodenum may be acute or chronic, both penetrate the 
muscularis mucosae but the acute ulcer shows no evidence of fibrosis.  Erosions do not penetrate the 
muscularis mucosae.   
 
AETIOLOGY 
Mucosal resistance against Acid – Pepsin  
 The immediate cause of peptic ulceration is digestion of the mucosa by acid and pepsin up 
the gastric juice, but the sequence events leading to this is unknow.  Digestion by acid and pepsin 
cannot be the only factor involved, because the normal stomach is obviously capable of resisting 
digestion by its own secretions.  The concept of ulcer aetiology may be written as acid plus pepsin 
versus mucosal resistance.  Some factors which affect this balance can be identified. 
Gastric Hypersecretion 
 Ulcers occur only in the presence of acid and pepsin; they are never found in achlorohydric 
patients such as those with pernicious anemia.  On the other hand severe intractable peptic ulceration 
nearly always occurs in patients with the zollinger – Elisson syndrome which is characterized by 
very high acid secretion.  Acid secretion is more important in the aetiology of duodenal than gastric 
ulcer, because patients with duodenal ulcer, as a group, secrete more hydrocholoric acid normal 
individuals. 
Mucosal Resistance 
 Several mechanisms protect the gastric mucosa from hydrogen ions secreted into the lumen 
of the stomach.  The surface epithelial cells secrete bicarbonate ions which creates an alkaline milieu 
at the surface of the mucosa; this bicarbonate secretion is under the influence of mucosal 
prostaglandins.  The fight function between the epithelial cells and their surface lipoprotein layer 
provide a mechanical barrier.  The normal turnover of epithelial cells and gastric mucous also has a 
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protective function, collectively, all these mechanisms can be described as the ‘Gastric mucosal 
barrie’.  Its integrity is important in preventing gastric ulcer and some of these mechanisms may also 
operate in the duodenum. 
Factors Reducing Mucosal Resistance 
 Several drugs particularly those used in Rheumatoid arthritis will disrupt the gastric mucosal 
barrier when aspirin is in solution at a PH below 3.5, it is undissociated a and fat-soluble, so that it is 
absorbed through the lipoprotein membrane of the surface epithelial cells; during absorption 
damages the membrane and the tight junctions.  It also inhibits prostaglandin synthesis thus reducing 
bicarbonate secretion by the surface epithelial cells.  Aspirin has been shown to be an important 
actiological factors in gastric ulcer.  There is also a relationship between aspirin ingestion and acute 
bleeding from the upper gastrointestinal tract. 
 
 Reflux of bile and intestinal secretions into the stomach occurs more frequently in patients 
with gastric ulcers than in normal individuals or patients with duodenal ulcer, due presumably to a 
poorly functioning pyloric sptineter.  Bile damages the gastric mucosal barrier, predisposing  the 
mucosa to ulceration chronic gastritis is more common in patients with gastric ulcer and it may be 
caused by damage from regurgitated bile and intestinal secretions.. 
Diet  
 The lack of protein deficient diet and untimely meals in these refined food resulting in a 
failure to gastric acid ingestion of refined cereals is the prominent factors in the increased incidence 
of duodenal ulcer. 
 
Smoking, Alcohol  
 Incidence of peptic ulcer is high among smokers than among non-smokers.  Gastric ulcer 
tend to heal more rapidly in patients who step smoking than in those who do not smoking decreases 
the therapy.  All these facts suggest that it is an actiological factor in the development of peptic ulcer.  
Gastric ulcer commonly occurs in association with alcoholic cirrhosis.   
Heredity 
 Patients with peptic ulcer often have a family history of the disease. This is particularly the 
case with duodenal ulcers which develops below the age of 20years. Gastric and duodenal ulcers are 
inherited as separate disorders; thus the relatives of gastric ulcer patients have three times the 
expected number of gastric ulcers but duodenal ulcer occurs with the same frequency amongst 
relatives as in the general population. 
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Stress induced ulcers  
 People who are highly nervous and emotional and who worry, fear and feel anxiety are 
particularly susceptible.  These emotional and nervous factors in turn may lead to hyper secretion 
and hyper mobility of the stomach the nervous control of the vascular system in the gastric on 
duodenal walls may be so disturbed that there is diminision in the blood supply to the mucosa of the 
stomach and duodenum making its susceptible to acid secretion. 
Helicobacter pylori 
               A major causative factor (60% of gastric and up to 90% of duodenal ulcers) is chronic inflammation 
due to Helicobacter pylori that colonizes the antral mucosa. The immune system is unable to clear the 
infection, despite the appearance of antibodies. Thus, the bacterium can cause a chronic active gastritis, 
resulting in a defect in the regulation of gastrin production by that part of the stomach, and gastrin secretion 
can either be decreased (most cases) resulting in hypo- or achlorhydria or increased. Gastrin stimulates the 
production of gastric acid by parietal cells and, in H. pylori colonization responses that increase gastrin, the 
increase in acid can contribute to the erosion of the mucosa and therefore ulcer formation. 
Drugs 
There is much suggestive evidence that treatment with aspirin. Phenylbutozone etc. may aggravate 
peptic ulcer incidence.  
Blood Groups  
 Peptic ulcer tends be more common in people with blood group ‘O’ Gastric ulcer tends to be 
more common in people with Blood Group ‘A’ 
Association with other Diseases  
 Peptic ulcers in association with almost all diseases, the incidents is noted in patients with 
Achlohydia namely pernicious  Anaemia and Atrophic Gastritis Gastric Carcinoma, Diapharagmatic, 
Herinia, Duodenal stasis, emphasema, corpulsmonale and Rheumatoid disease, Cirrhosis of liver, 
Tuberculosis. 
Occupational Factors  
 The occupational survey carried out by hussian from Hyderabad reported that 60% duodenal 
ulcer cases were in farmers.  It may be trace that peptic ulcer is commonamong south Indian 
agriculturists.  It is also common is executives, doctors and industrialists. 
Pathology 
 Chronic gastric ulcer is usuallysingle; 90% are situated on the lesser curve within the antrum 
or at the junction between body and antral mucosa, chronic duodenal ulcer is usually in the first part 
of the duodenum just distal to the junction of pyloric and duodenal mucosa; 50% are on the anterior 
wall, more than one peptic ulcer is found in 10 – 15% of patients acute ulcers on erosions are 
frequently multiple, and are more widely distributed. 
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Clinical Features 
 A duodenal ulcer follows a chronic course for upto 20 years and while the treatment with 
histermine H2 – receptor antagonist drugs may effect prompt healing, there is no evidence that the 
natural history of the ulcer is affected.  The course of gastric ulcer is probably less chronic.  While 
there are good grounds for believing that gastric and duodenal ulcers are different deceases it is 
convenient to describe  the general features of  “Peptic Ulcer” as inclusive of both, there is no 
difference in their occurrence. 
 Peptic ulcer may be present in different ways.  The commonest is chronic, episodic pain 
extending over months on years.  However, the ulcer may come toa attention as an acute episode 
with bleeding or perforation, with little or no previous history, occasionally the patient presents with 
the symptoms of gastric outlet obstruction, having negligible trouble previously. 
 Pain is the characteristic symptoms of peptic ulcer, and it has three notable features, 
localization to the epigastrium, relationship to food and periodicity. 
 Ulcer pain is typically referred to the epigastrium it is localised usually in the acid line or to 
the right.  So that the patient can indicate the site with one finger,   ‘the pointing sign’.  Occasionally 
ulcer pain is not clearly localised, it may be referred diffusely in the epigastricum, the lower chest or 
to the back in the interscapular region in the fifth to eighth thoracic segments. 
 Pain referred to the inter scapular area suggests duodenal or post bulbar ulceration.  The 
description of the pain is not especially helpful, although patients commonly describe it as gnawing 
or burning. 
 Most patients recognized a relationship of the pair to the food, although the relationship 
varies between patients,  and in the same patient from time to time. Duodenal ulcer pain tends to 
occur between meal times, so that the patient may describe it as ‘hunger’ pain, which is 
characteristically relieved by food. A notable feature of duodenal ulcer is pain awakening the patient 
from sleep 2 to 3 hours after refising. The pain of gastric ulcer occurs less regularly; it frequently 
occurs within an hour of eating, is less often relieved by food and it rarely occurs at night. Besides 
the characteristic relief obtained after eating, ulcer pain is almost invariably relieved  by antacids or 
by vomiting.  
 Ulcer pain is characteristically episodic occurring regularly then disappearing to recover 
ulcers or months later.  Between attacks, the patient feels perfectly well, and may eat and drink with 
impunity.  Bouts of pain may at first last only a day os so at a time, and occur only once or twice a 
year.  As the natural history evolves, however episodes begin to last longer and occur more 
frequently, so that in severe cases remissions of pain may be short lived and pain or discomfort 
becomes more or less persistent.  The cause for these relapses is difficult to be established seasonal 
factors may be operative, sometimes psychological stress may be blamed, sometimes, dietary 
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indiscretion and sometimes alcohol in excess.  Most commonly no reason can be found for the 
relapse. 
 Pain is sometimes absent or so slight as to be described by the patient.  Such individuals may 
complain of other symptoms such as a feeling of “Distension” in the epigastrium or a poorly defined 
sense of unease after eating.  Other complaints include episodic nausea and sometimes anorexia,  as 
well as heartburn or water brash vomiting in clear patients almost always relieves pain and when it is 
persistent may result in weight loss.  This helps to distinguish it from vomiting  of psychological 
origin, in which weight is usually maintained.  Persistent vomiting in an ulcer subject usually 
indicates some degree of gastric narrowing.  In such patients, vomiting is usually copious, so that the 
patient is “surprised” at the volume, the patient often recognizes food ate twelve on more hours 
previously.  Although there is no constant change in bowel rhythm during an ulcer relapse, some 
patient are aware of constipation or diarrhea when dyspepsia reappears.  
Physical Signs 
 The only physical sign that may be present is ‘the pointing sign’ which, when accompanied 
by localized tenderness, is practically diagnostic of an ulcer.  However, tenderness may be 
completely absent, in patients with gastric outlet obstruction, the stomach may be visibly distended, a 
succession splash may be present and gastric peristalsis may be seen. 
Effect of Diet, Drugs, Tobacco and Alcohol 
 There is no evidence that dietary manipulation affects the symptoms on ulcer healing and 
therefore strict diets should be avoided.  It is particularly important that aspirin and other anti 
inflammatory drugs are not used in peptic ulceration.  Their injurious action should be explained to 
the patient.  There is on evidence that shopping smoking accelerates the healing of gastric ulcers and 
it is likely to be applied to duodenal ulcers patients should therefore be advised to give up smoking 
exacerbations of ulcer disease because it aggravates their symptoms.   It seems reasonable to 
encourage moderation in drinking habits in all patients with peptic ulceration. 
Surgical Treatment 
 This has much to offer the patient with intractable peptic ulceration.  It can relieve severe or 
persistent symptoms and prevent complications.  While in many patients the assessment of the 
disability is straight forward, in those in whom anxiety or depression in present, the decision 
becomes difficult.  Elective surgery should be considered in the following circumstances.  When the 
ulcer relapses after several courses cimetidine or ranitidine, or more rarely when the ulcer fails to 
heal at all, particularly when symptoms, interfere with the enjoyment of life of reduce the capacity to 
work.  The indications for surgery are strengthened if the ulcer has developed in adolescence or 
young adult life if there is a strong family history or if there has been previous complication such as 
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hemorrhage or perforation.  Finally, some patients fail to comply with medical therapy or express 
reservations about prolonged therapy.  Both points being in favour of elective surgical treatment. 
Complications 
 Complications of peptic ulcer are hemorrhage perforation and gastric out let obstruction and 
ulcer cancer. 
Gastric duodenal Hemorrhage 
 Gastro duodenal hemorrhage is recognized by hacmatenesis (vomiting of blood) and or 
melaena  (passage of blood in the stools) and usually there are symptoms of hypovolaemia.  Upper 
gastro intestinal haemorrhage carries a mortality that may reach 30% in elderly and shocked patients.  
A history of significant blood loss within the previous 48 hours should lead to immediate admission 
to hospital. 
Acute Perforation of a Peptic Ulcer: 
 When free perforation occurs, the contents of the stomach escape into the peritoneal cavity.  
It perforation occurs without loss of contents as in the accidental perforation of the empty stomach at 
gastroscopy, few symptoms are produced and the accident may even pass unnoticed.  It follows that 
the symptoms of perforation are those of peritonitis, and they are in proportion to the extent of 
peritoneal soiling.  Occasionally the symptoms of perforation appears and rapidly subside, pre 
sumably the perforation has then closed spontaneously, or more commonly the ulcer has perforated 
locally into an area confined by adhesions to adjacent structures.  Pertoration occurs more commonly 
in duodenal than in gastric ulcers and usually in ulcers on the anterior wall.  About one quarter of all 
perforations occur in acute ulcers. 
 Acute perforation carries a mortality of about 5%.  The outlook is poorest in elderly patients.  
When a large perforation results in extensive peritonitis on when operation is delayed.  
Gastric Outlet obstructions:  
 An ulcer in the region of the pylorus may result in gastric outlet obstruction.  This may be 
due to fibrous structure or to oedema or spasm produced by the ulcer, frequently it is a combination 
of all three, Long-standing obstruction may lead to severe. ‘Retention gastritis’ on even the 
secondary gastric ulcer. 
 In addition to chronic duodenal ulcer, or benign gastric ulcer at or near the pylorus, gastric 
outlet obstruction may be caused by carcinoma of the antrum and by a rare condition known as adult 
hypertrophic pyloric stenosis. 
 The syndrome of gastric outlet obstruction is loosely described as ‘pyloric stenosis’.  Even 
when the cause is chronic duodenal ulcer, and the stenosis is distal to the pylorus thus in ‘Pyloric’ 
obstruction due to duodenal stenosis, the pylorus itself may be seen radiologically to be greatly 
dilated.  
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Zollinger – Ellison Syndrome: 
 This is a rare disorder in which severe peptic ulceration occurs due usually to an adenoma or 
hyperplasia of the islets of the pancreas secreting large amount of gastrin which  stimulates the 
parietal cells of the stomach excessively.  The acid output may be so great that the ‘acid tide’ may 
reach the upper small intestine, reducing the luminal PH to 2 og less at the pH pancreatic lipase is 
inactivated and bile acids may be precipitated, causing diarrhea and steaforrhoea .  Excessive gastric 
secretion results in large volumes on aspiration under ‘basal’ conditions.  Pentagastrin does not 
increase  The secretary rate much above ‘basal’, values, since the stomach is already continuously 
secreting at or near nominal rates. 
 
Clinical Features: 
 The ulcers are often multiple and severe and may occur in unusual sites such as the jejunan or 
the oesophagus. The history is usually short and bleeding and perforation are common.  The 
syndrome may present form of severe recrurrent ulceration following a standard operation for peptic 
ulcer, the underlying cause not having been recognized. 
 The diagnosis should be suspected in all patients with unusual or severe peptic ulceration 
especially coarse barium meal examination shows  abnormally coarse gastric mucosal folds.  It may  
be confirmed by finding very high levels of gastrin in the circulation. 
 
DIFFERENTIAL DIAGNOSIS: 
1. Chronic intestinal Amoebiasis: 
 History of recurrent dysentery, caecum and pelvic color are tender and cord like, liver   
             may be palpable and tender, stool may show cysts of entamoeba histolytica.  
2. Chronic cholcystitis: 
 There may be history of biliary colic and jaundice in the past, murphy’s sign is  
           positive. Rarely gull bladder may be palpable.  Chlocytography settles the diagnosis by 
showing dysfunction of the gall bladder with or without stone. 
3. Chronic Appendicitis: 
 There may be history of acute appendicitis in the past, Mcburney’s point is tender,  F.T.M. 
and barium meal x-ray of appendix may show irregularity or no filling. 
4. Chronic Gastritis: 
 There is anorexia, discomfort in the upper abdomen without any definite tenderness, F.T.M. 
shows low acid but excess of mucous in all samples, barium meal x-ray shows coarse or tine gastric 
rugae. 
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5. Chronic Pancreatitis: 
 There may be history of acute pancreatitis in the past, pain radiating to the back may be 
present without definite relation with food.  Steatorrhoea and diabetes mellitus may be present, X –
ray of the abdomen may reveal pancreatic calcification. 
 
SPECIAL INVESTIGATIONS: 
1.     Endoscopy in Gastro – Entrology: 
 In recent years endoscopic photography, both still and motion, has become possible and gives 
excellent pictures. The flexible fibroscope now enables one to examine the oesophagus, stomach and 
duodenum and at the same time obtain biopsies and material for cytological examination. 
 It is used in diagnosis purpose for the oesophagitis, oesophageal ulcer, gastric ulcer, duodenal 
ulcer, duodenitis malignant cancer, biopsy can also be obtained to find out in gastric ulcer is benign 
or malignant. 
 
2.   Fractional  Test Meal: 
 The patient who was on starvation during the previous night is asked to swallow the ryles 
tube at 5 a.m. and the entire stomach contents a fasting juice are aspirated with a donel, record 
syringe.  The patient is them given a pint of warm gruel to drink the gruel is prepared by boiling two 
table spoonfuls of the oatiomeal in two  pints of water until the quantity is reduced to one pint.  
Every 15 minutes not more than 15 ml of gastric contents is now aspirated until 2 ½ hours have 
elapsed or until such time as 15ml can no longer be aspirated.  These samples are examined for total 
acidity, free Hcl, bile, blood, mucous and starch and the results recorded on a chart  In a gastric ulcer, 
the cures of tree hel, and total acidity are high, normal or just above the normal limit.  Blood may be 
present in some of the specimen.  The climbing curve is due to pylorospasm which prevents 
regurgitation of bile or allows the acidity to rise continuously.  Besides carcinoma achlorhydria is 
found in pernicious anaencia, gastritis, chronic appendicitis, etc, but association or blood in all the 
specimen is strongly suggestive of a carcinoma.  Sometimes cancer cells can be demonstrated into 
washing after gastric lavage. 
 
 This test is no more needed to make correct diagnosis of peptic ulcer except to exclude the 
role of vagatomy during surgical management. 
 
3. Examination of stool: 
 Black and farry stool melacna is well known in a peptic ulcer when the hemorrhage is large.  
Small hemorrhage need special chemical test for detection. 
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4.         Elisa test for H-pylori 
            The Pyloriset EIA-A III is an enzyme immunoassay for the detection and measurement of H. 
pylorispecificIgA antibodies in human serum as an aidin diagnosing infection. The product is used to 
testpatients with symptoms of gastrointestinal disordersand as a follow-up to medical treatment In 
the assay, the serum samples are added to the microtiter wells coated with specific H. pylori 
antigens. If anti-H. pylori IgA is present in the specimen, it will bind to the antigen bound to the 
surface of the wells. The residual test specimen is washed away, and horseradish peroxidase-
conjugated anti-human IgA reagent is added. Enzyme conjugate binds to an antigen-antibody 
complex, unbound conjugate is washed away, and a substrate is added. After stopping the substrate 
reaction, the color is measured using a photometer. The intensity of the Color 
 is proportional to the concentration of the H pylori-specific antibody in the sample . 
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MATERIALS AND METHODS 
 In my clinical study among 40 patients, 20 cases of “Eri Gunam” patients were admitted in 
postgraduate department of Maruthuvam, Govt. Siddha Medical College Hospital, in-patient ward, 
and 20 cases were treated in the hospital out-patient department, Chennai-106. 
 These patients were subjected to a careful examination and the diagnosis was made by Siddha 
Clinical Methodology and Modern methods.  
Patients were selected based on the following signs and symptoms: (inclusion criteria) 
 Duration of the illness not more than 10 years. 
 Epigastric pain with relation to food. 
 Abdominal Discomfort 
 Diarrhoea 
 Weight loss 
 Patients belonging to age group of 20 – 80 years. 
Patients were exhausted for the following Criteria: (exclusion criteria) 
 Duration of illness more than 10 years 
 Pyloric stenosis 
 Malignancy in the stomach and in the other parts of the body. 
 Acute abdominal colics 
 Pain due to gallbladder stone (or) pancreatitis. 
 Patients belonging to age groups below 20 and above 80 years. 
Patients from both sexes of various age groups were admitted based on the above criteria.  
First priority was given to clinical findings and confirmatory diagnosis was made by conducting all 
the necessary investigation in Siddha as well as modern aspects.  Hence from these signs and 
symptoms of Eri Gunmam correlates with the peptic ulcer in modern system of medicine 
investigations, which meant for peptic ulcer in modern medicine is carried out endoscopy for Eri 
Gunmam also. 
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Siddha diagnosis was made with the help of the following criteria: 
Regarding Siddha System: 
1. Thinaigal (Ivagai Nilai) 
2. Paruva Kalangal 
3. Mukkutra Nilaigal 
4. Elu Udal Kattugal 
5. Envagai Thervugal  
In Modern system of Medicine the following investigation were done: 
Routine Laboratory Investigations: 
1. Haemotological  investigations: 
 Total WBC count 
 Differential WBC Count 
 Erythroucyte sedimentation rate (ESR) 
 Haemoglobin percentage (Hb%) 
 Blood Sugar, Urea 
 Blood Groups 
 Serum cholesterol. 
2. Urine Analysis 
 Albumin 
 Sugar 
 Deposits 
3. Stools Examination 
 Ova 
 Cyst 
 Occult blood 
4. Special Investigation 
 Endoscopy 
 Serum Amylase 
 USG Abdomen 
    
61 
 
Selection of medicines: 
 Selection of medicines was made after in depth study of various siddha literatures. 
 
The test medicines are 
1. Gunmathi Choornam – 1 g  3 times / day with Hot water / milk, After Food. 
2.   Musumusukai Lehyam -  5 gm 2 times / day after food. 
The biochemical constituents and microbiological effects of the drug were studied.  The drug 
was also subjected to the pharmacological and toxicological tests in Albino rat modes. 
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Results and 
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RESULTS AND OBSERVATIONS 
 For this study 40 cases were selected.  all these cases clinical examinations under both Siddha 
and modern aspects were observed and results were taken.  Results were observed with respects to 
the following criteria. 
 Sex distribution 
 Age distribution 
 Socio-Economic Status 
 Duration of illness 
 Dietary habits 
 Nilam (Thinai) 
 Paruva Kaalam 
 Kaalam 
 Religion Reference  
 Distribution of Vatham, pitham, kabham 
 Udal Kattugal 
 Envagai Thervugal 
 Naadi 
 Blood Grouping 
 Clinical Features 
 Results. 
All the patients were treated with medicines. 
1.          Gunmathi Choornam – 1 g  3 times / day with Hot water / milk, After Food. 
2.   Musumusukai Lehyam -  5 gm 2 times / day after food. 
 Among the 40 cases the epigastric pain, burning sensation, abdominal discomfort, diarrhoea, 
and weight loss and other symptoms were relieved after the administration of the medicines 
Digestion with good appetite and no chronic effects were observed. 
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1. SEX DISTRIBUTION 
S.No. Sex No. of cases Percentage % 
1. Male 23 57.5% 
2. Female 17 42.5% 
             
 
 
 
 
     
              
 
 
Inference: 
 Out of 40 patients 23 cases (57.5%) were male and 17 cases (42.5%) were female. 
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2. AGE DISTRIBUTION 
S.no Age No of cases Percentage % 
1 21-30 7 17.5% 
2 31-40 9 22.5% 
3 41-50 13 32.5% 
4 51-60 5 12.5% 
5 61-70 4 10.0% 
6 71-80 2 5.0% 
  
 
 
 
Inference: 
 Among 40 patients, 7 belong to age group 21 – 30 and 9 patients belong to age group  
31 – 40, 13 patients belong to age group 41 – 50, 5 patients belong to age group   51 – 60, 4 patients 
belong to age group 61 – 70. And 2 patient under 71-80 age group. Maximum patients found   
between age group of 41 – 50. 
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3.  SOCIO ECONOMIC STATUS 
S.No. Socio Economic Status with 
income group 
No. of cases Percentage% 
1. Poor (Below 5000) 32 80.0% 
2. Middle (5001 to 10000) 6 15.0%  
3. Rich (Above 10000) 2  5.0% 
 
 
 
 
 
 
  
 
Inference: 
 Among 40 patients, 32 (80%) were poor, 6 (15%) were middle class and 3 (5%) were rich.  
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4.  DURATION OF ILLNESS 
 
S.No. Duration No. of cases Percentage % 
1. 1 month to 6 months 12 30% 
2. 6 months to 1 year 14 35% 
3. 1 year to 3 years 10 25% 
4. 3 years to 5 years 4 10% 
5. 5 years and above - - 
 
 
 
 
 
  Inference 
 Most of the cases selected duration of illness is 6 months to 1 year.     
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5.   HABITS WISH DISTRIBUTION 
S.No. Habits No. of cases Percentage% 
1. Vegetarian  4 10% 
2. Non Vegetarian  20 50% 
3. Alcohol 12 30% 
4. Smoker 4 10% 
 
 
 
 
 
  
 
Inference: 
 Among 40 patients, 4 (10%) were Vegetarian, 20 (50%) were Non-Veg and 12 (30%) were 
alcoholic, 4(10%) were smoker. 
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6. NILAM / THINAI 
S.No. Duration No. of cases Percentage % 
1. Kurinji (Hill Area) 0 0% 
2. Mullai (forest area) 0 0% 
3. Marutham (Fertill Area) 5 12.5  % 
4. Neithal (costal Area) 35 87.5 % 
5. Paalai (Desert Area) 0 0% 
 
 
 
Inference: 
Among 40 cases, 35 were belonged to Neithal Nilam, and 5 were belonged to Marudham .  
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7. PARUVA KALAM 
S.No. Paruva Kalam Months No. of 
cases 
Percentage% 
1. Kar Kalam Avani- Puaratasi (Aug 15 – Oct 15) 10 25.0% 
2. Koothir kalam Iypasi –Karthigai (Oct 15 – Dec 15) 2 5.0% 
3. Munpani Margazhi-Thai (Dec’5 – Feb’5) 0 0% 
4. Pinpani Nasi – Panguni (Feb 15 – April 15) 0 0% 
5. Ilavenil Chithirai –Vaikasi (April 05-June 15) 1 2.5% 
6. Mudhuvenil Anni- Aadi (June 15 – Aug 15) 27 67.5% 
 
 
Inference 
 Among 40 cases 27 cases were belonged to Mudhuvenil Kaalam, 10 cases under Kar kalam,2 
cases belonged to Koothir kaalam and 1 were belonged to Ilavenil Kaalam, 
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8.  KAALAM 
S.No. Kaalam No. of cases Percentage% 
1. Vatham 12 30% 
2. Pitham 23 57.5% 
3. Kabam 5 12.5% 
  
 
 
Inference: 
 Vatha Kaalam lies up to 33rd age of a person, Pitha Kaalam lies between 33rd to 66th age, 
Kabba kaalam lies above this age.  The maximum no of patients of ERI Gunam cases were in Pitha 
Kaalam       
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9.  RELIGION REFERENCE 
S.No. Religion No. of cases Percentage% 
1. Hindu 37 92.5% 
2. Christian 2 5.0% 
3. Muslim 1 2.5 % 
 
 
 
 
 
Inference:  
    Most of the patients religion Hindu 92.50% and Muslims 2.50 %,Christian 5.00 %. 
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10.  DISTRIBUTION OF THRI-DHOSAM 
 The derangements of the three vital phenomena in 40 cases were studied. 
S.No . Vatham No. of cases Percentage% 
1. Pranan 0 - 
2. Abanan 8 20% 
3. Viyanan 40 100% 
4. Uthanan 40 100% 
5. Samanan 40 100% 
6. Nagan 0 - 
7. Koorman 0 - 
8. Kriugaran 18 45% 
9. Devathathan 9 22.5% 
10. Thananjeyan - - 
 
Inference: 
 Vatha derangement was noted with the disturbance of 10 vaayus, Viyaanan, Uthanan, 
Samanan and Abanan were the 4 vaayus, mostly affected.  
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11.  PITHAM 
S.No. Pitham  No. of cases Percentage% 
1. Analagam 40 100% 
2. Ranjagam 18 45% 
3. Saathagam 40 100% 
4. Pirasagam 0 - 
5. Alosagam 0 - 
 
  
 
 
Inference: 
In the above five pithas Analagam and Saathagam were mostly affected in the 40 cases. 
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12.  KABAM 
S.No. Kabam No. of cases Percentage% 
1. Avalambagam 0 0% 
2. Kilethagam 40 100% 
3. Pothagam 20 50% 
4. Tharpagam 0 0% 
5. Sandhigam 0 0% 
  
 
 
  
Inference: 
From this study, it is seen that in all the cases Kilethagam was chiefly affected in100% and in 
50% of the cases pothagam was affected. 
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13.  UDAL KATTUGAL 
S.No. Udal Kattugal No. of cases Percentage% 
1. Saram 40 100% 
2. Senner 18 45% 
3. Oon 4 10% 
4. Enbu 0 0% 
5. Kozhupu 0 0% 
6. Moolai 0 0% 
7. Chukkilam/surouitham 0 0% 
  
 
 
Inference: 
 In all the cases, Saaram was chiefly affected in 100% of the cases, seneer had been affected 
in 45% of the cases, Oon was affected in 10% of the cases. 
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14.  ENVAGAI THERVUGAL 
S.No. Envagai thervugal No. of cases Percentage% 
1. Naa 20 50% 
2. Niram 18 45% 
3. Mozhi 0 0% 
4. Vizhi 0 0% 
5. Sparisum 0 0% 
6. Malam 8 20% 
7. Moothir 0 0% 
8. Naadi 40 100% 
              
 
 
           Inference: 
After the confirmation of diagnosis as Gunmam, the type of Gunmama is confirmed by 
comparing the identies and differences of signs and symptoms and results obtained by Envagai 
Thervugal.  
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15. NAADI 
S.No. Naadi  No. of cases Percentage% 
1. Vatha Pitham 29 72.5% 
2. Pitha Vatham 11 27.5% 
 
 
 
       
 
Inference: 
Among 40 cases 72.50% patients have Vatha pitham and 27.50% Pitha Vatham. 
 
 
 
 
 
72.50%
27.50%
Percentage %
Vatha Pitham
Pitha Vatham
    
79 
 
16.  BLOOD GROUPING  
S.No. Blood Grouping No. of cases Percentage% 
1. A 13 32.5% 
2. B 2 5% 
3. AB 1 2.5% 
4. O 24 60% 
    
 
 
           
 
Inference: 
From this study it is seen that maximum incidence of the disease Eri Gunmam seen in the 
patients belonged to “O” Group. 
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17. CLINICAL FEATURES 
  No. of patients affect  No. of patients improved  
S.No. Symptoms Before 
treatment 
Percentage
%  
After 
treatment 
Percentage % 
1. Epigastric pain 20 50% 19 47.5% 
2. Heart burn 12 30% 8 20% 
3. Abdominal discomfort 30 75% 26 65% 
4. Pain related to food 30 75% 28 70% 
5. Radiating Pain 12 30% 10 25% 
6. Tenderness in 
epigastric  region 
30 75% 28 70% 
7. Diarrhoea 8 20% 8 20% 
8. Loss of weight 4 10% 3 7.5% 
 
 
Among 20 patients 19 pts improved from Epigastric Pain 
Among 12 patients 8 pts improved from Heart burn 
Among 30 patients 26 pts improved from Abdominal discomfort 
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Among 30 patients 28 pts improved from pain related to food. 
 
Among 12 patients 10 pts improved from radiating pain. 
 
Among 30 patients 28 pts reatigot relief from tenderness in Abdominal region. 
 
Among 8 patients 8 pts got relief from Diarrhoea. 
 
Among 4 patients 3 pts improved from loss of weight. 
 
 
 
18.  RESULTS 
S.No. Results No. of cases Percentage% 
1.  Improved 30 75 % 
2. Symptoms relieved 10 25 % 
     
 
               
Inference: 
 Results obtained Were 
 75% of cases Improved. 
 25% of cases Symptoms relieved 
The results were based on clinical improvement. 
 
 
 
75%
25%
Percentage %
 Improved
Symptoms relieved
    
82 
 
S.No Name of the 
Patients 
Blood 
Group 
Age/ 
Sex 
B.T Indication A.T 
1. Lakshmi  A 35/F  Taken Gastric Ulcer Improved 
2. Visvanathan  O 50/M Not 
Taken 
Gastric ulcer  Symptoms 
relieved 
3. Gowthmraj A 25/M Not 
Taken 
Gastric Ulcer Symptoms 
relieved 
4. Tamilarsan O 30/M  Taken Duodenal Ulcer Improved 
5. Susila A 48/F  Taken Duodenal ulcer Improved  
6. Balu A 42/M Not 
Taken 
Gastric ulcer  Symptoms 
relieved 
7. Paul O 32/M Taken  Duodenal Ulcer Improved 
8 Nagaraj A 32/M Taken Duodenal Ulcer Improved 
9. Parthasarathi O 28/M Not 
Taken 
Gastric ulcer  Symptoms 
relieved 
10. Govindraj O 42/M Not 
Taken  
Gastric Ulcer Improved 
11. Ramkumar O 32/M Not 
Taken 
Gastric ulcer  Improved 
12. Senthilvel O 30/M Not 
Taken 
Gastric ulcer  Improved 
13. Ramu AB 31/M Taken Gastric Ulcer Improved 
14. Mahendran O 29/M Not 
Taken 
Duodenal Ulcer Improved 
15. Deenadayalan A 33/M Not 
Taken 
Duodenal Ulcer Improved 
16. Rathikumar O 37/M Taken Gastric Ulcer Improved 
17. Rani O 44/F  Taken Gastric Ulcer Symptoms 
relieved 
18. Gnnasekaran A 48/M Not 
Taken 
Duodenal ulcer  Improved 
19. Karthikayan A 21/M Taken 
   
Duodenal Ulcer Improved 
20. Shakthivel O 29/M Not 
Taken 
 
Duodenal Ulcer Improved 
21. Lakshmidevi B 38/F Not 
Taken 
Gastric Ulcer Improved 
22. Poongavanam O 70/F Not 
Taken 
Gastric ulcer  Symptoms 
relieved 
23. Thayammal O 70/F Not 
Taken 
Duodenal Ulcer Improved 
24. Amsavalli O 66/F Not 
Taken 
Duodenal Ulcer Improved 
25. Mari O 50/M Not 
Taken 
Gastric ulcer  Improved 
26. Deivanai O 47/F Not 
Taken 
Gastric ulcer Improved 
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27. Thilagam  O 50/F Not 
Taken 
Gastric ulcer Improved 
28. Nagammal A 60/F Not 
Taken 
Duodenal ulcer  Symptoms 
relieved 
29. Palani O 50/M Not 
Taken 
Duodenal Ulcer Improved 
30. Ameer  O 75/M Not 
Taken 
Gastric ulcer  Improved 
31. Gajendran O 60/M Not 
Taken 
  
Gastric ulcer Improved 
32. Selvi O 50/F Not 
Taken 
Duodenal Ulcer Symptoms 
relieved 
33. Marimuthu A 60/M Not 
Taken 
Gastric ulcer  Improved 
34. Papathi O 59/F Not 
Taken 
Gastric ulcer  Improved 
35. Shankar B 35/M Not 
Taken 
Gastric Ulcer Improved 
36. Dharani O 72/M Not 
Taken 
Duodenal Ulcer Symptoms 
relieved 
37. Veerappan A 40/M Not 
Taken 
Duodenal Ulcer Improved 
38. Vijalakshmi O 60/F Not 
Taken 
Gastric ulcer  Improved 
39. Usha A 43/F Not 
Taken 
Duodenal ulcer  Symptoms 
relieved 
40. Sargunam O 46/F Not 
Taken 
Gastric ulcer   Improved 
 
 
Even though all patients were insisted for endoscopic investigations, only 11 of them was willing 
,since others faceing inconveniences during these investigation before treatment. 
 Other than these endoscopic investigations, rests of the patients are clinically diagnosed by 
their clinical features, signs and symptoms. 
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LABORATORY INVESTIGATION REPORTS  (OP/IP) 
 
TC – Total Count ,  Hb – Hemoglobin,   Dc – Differential Count , P – Polymorph,  L – Lymphocyte , E – Eosinophil ,  ESR – Erythrocyte Sedimentation Rate, OEC – Occasional Epithelial Cells 
OPC – Occasional Pus Cells, FPC – Few Pus Cells,  FEC – Few Epithelial Cells , OB    - Occult Blood,  Alb – Albumin,  Sug – Sugar , Dep – Deposits. 
 
Sl. 
No. 
O.P. 
No. 
Name/SEX Age 
HAEMATOLOGICAL REPORT URINE ANALYSIS STOOL ANALYSIS  
BEFORE TREATMENT AFTER TREATMENT ESR (mm) Hb(Gm) BT AT BT AT 
TC 
CU/m
m 
DC %  TC 
CU/m
m 
DC % BT AT 
BT AT Alb Sug Dep Alb Sug Dep OB OB 
 
P L E P L E 
½ 
hr 
1 
hr 
½ 
hr 
1hr 
1. 573 LAKSHMI/F 35  9000 55 38 7 10500 62 34 4 22 45 15 30 9.0 12.5 NIL NIL Opc NIL NIL NIL      NIL      NIL 
2. 222 VISVANATAN/M 50 9400 59 36 5 10100 62 34 4 5 12 4 7 11.8 13.5 NIL NIL Opc NIL NIL NIL NIL NIL 
3. 593 TAMILARSAN/M 30 10100 57 30 
1
3 
9600 53 39 8 10 22 7 15 9.0 13.4 NIL NIL Opc NIL NIL NIL NIL NIL 
4. 3095 
GOWMTHAMRAJ
/M 
25 9000 57 39 4 9800 60 36 4 5 11 5 10 13.0 15.0 NIL NIL Opc NIL NIL Opc NIL NIL 
5. 932 SUSILA/F 48 10200 62 33 5 10000 52 33 5 15 38 10 22 10.4 12.5 NIL NIL Opc NIL NIL NIL NIL NIL 
6. 7082 BALU/M 42 9400 59 36 5 9800 60 36 4 15 5 11 30 12.4 15.0 NIL NIL Opc NIL NIL Opc NIL NIL 
7. 737 PAUL/M 32 7800 56 38 6 10100 60 36 4 2 7 5 10 8.0 11.5 NIL NIL Opc NIL NIL NIL + NIL 
8. 3497 NAGARAJ/M 32 9800 59 36 5 10200 60 34 6 3 6 5 10 16.0 12.4 NIL NIL Opc NIL NIL Opc NIL NIL 
9. 5510 
PARTHASARATH
Y/M 
28 9800 59 37 4 8900 55 41 4 15 20 5 12 13.0 12.0 NIL NIL Opc NIL NIL Opc NIL NIL 
10. 2932 GOVINDRAJA/M 32 10200 60 34 6 10400 60 36 4 5 11 25 60 13.0 12.5 NIL NIL Opc NIL NIL NIL NIL NIL 
11. 6735 RAMKUMAR/M 32 10400 60 34 6 9600 50 45 5 8 25 12 25 13.0 15.0 NIL NIL Opc NIL NIL NIL NIL NIL 
12. 6889 SENTHILVEL/M 30 9100 57 38 5 9800 60 34 6 5 20 15 33 11.2 8.0 NIL NIL Opc NIL NIL Opc NIL NIL 
13. 6729 RAMU/M 31 9700 57 38 5 9200 55 41 4 5 12 5 11 12.0 12.0 NIL NIL Opc NIL NIL Opc NIL NIL 
14. 8886 MAGENDRAN/M 29 9800 57 39 4 9400 57 38 5 12 13 10 18 10.0 13.4 NIL NIL Opc NIL NIL Opc NIL NIL 
15. 8045 
DEENADAYALAN
/M 
33 9700 59 33 8 9700 69 33 8 5 13 8 18 12.6 12.6 NIL NIL Opc NIL NIL NIL NIL NIL 
16. 6684 RATHIKUMAR/M 37 10000 57 38 5 9000 54 42 4 5 12 5 7 16.0 13.0 NIL NIL Opc NIL NIL Opc NIL NIL 
17. 2430 RANI/F 44 9000 53 40 7 10200 61 35 4 9 25 7 12 10.0 12.0 NIL NIL Opc NIL NIL NIL NIL NIL 
18. 1733 GYNASEKAR/M 48 10400 66 28 6 10100 60 36 4 7 16 10 15 12.0 14.5 NIL NIL Opc NIL NIL Opc NIL NIL 
19. 7400 KARTHIKAYAN/M 21 9000 54 42 4 9800 56 41 3 2 8 5 11 12.0 15.0 NIL NIL Opc NIL NIL NIL NIL NIL 
20. 8357 SAKTHIVEL/M 29 9400 55 41 4 9500 61 35 1 2 4 5 10 12.5 14.0 NIL NIL Opc NIL NIL Opc NIL NIL 
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Sl. 
No. 
I.P. No. Name/SEX Age 
HAEMATOLOGICAL REPORT URINE ANALYSIS STOOL ANALYSIS  
BEFORE TREATMENT AFTER TREATMENT ESR (mm) Hb(Gm) BT AT BT AT 
TC 
CU/m
m 
DC %  TC 
CU/m
m 
DC % BT AT 
BT AT Alb Sug Dep Alb Sug Dep OB OB 
 
P L E P L E 
½ 
hr 
1 
hr 
½ 
hr 
1hr 
1. 
826/ 
5908 
LAKSHMIDEVI/F 38  9200 53 41 6 9000 56 44 4 20 50 15 30 8.7 12.5 NIL NIL Opc NIL NIL NIL      NIL      NIL 
2. 
600/ 
7040 
POONGAVANAM
/F 
70 6100 60 41 5 9000 56 40 3 60 90 10 25 5.0 12.0 NIL NIL Opc NIL NIL NIL NIL NIL 
3. 
122/ 
8665 
THAYAMMAL/F 70 8700 58 36 6 9200 58 34 3 28 17 12 20 9.5 11.5 NIL NIL Opc NIL NIL NIL NIL NIL 
4. 
156/ 
9347 
AMSAVALLI/F 66 9500 55 32 4 9000 52 34 3 7 18 10 15 9.0 12.0 NIL NIL Opc NIL NIL Opc NIL NIL 
5. 
941/ 
169 
MARI/M 50 10600 62 30 8 9200 53 32 4 15 35 10 15 11.5 14.0 NIL NIL Opc NIL NIL NIL NIL NIL 
6. 
630/ 
8078 
DEIVANAI/F 47 10700 60 36 4 9600 60 34 3 14 40 10 15 9.0 11.5 NIL NIL Opc NIL NIL Opc NIL NIL 
7. 
875/ 
7739 
THILAGAM/F 50 9000 55 38 4 9000 53 34 3 40 72 20 30 6.0 10.5 NIL NIL Opc NIL NIL NIL NIL NIL 
8. 
214/ 
6518 
NAGAMMAL/F 65 9000 53 37 8 9200 56 39 3 27 50 12 25 9.0 11.5 NIL NIL Opc NIL NIL Opc NIL NIL 
9. 
52/ 
5207 
PALANI/M 50 9000 59 38 3 9000 60 40 3 12 39 12 22 11.5 10.5 NIL NIL Opc NIL NIL Opc NIL NIL 
10. 
690/ 
1214 
AMEER/M 75 9800 57 39 4 9200 63 40 3 10 16 12 22 8.0 12.5 NIL NIL Opc NIL NIL NIL NIL NIL 
11. 
816/ 
5632 
GAJENDRAN/M 60 9600 59 35 6 9000 60 35 4 55 87 20 32 9.0 11.5 NIL NIL Opc NIL NIL NIL NIL NIL 
12. 
789/ 
4600 
SELVI/F 55 9400 53 31 4 9000 60 42 4 25 32 12 20 9.5 11.0 NIL NIL Opc NIL NIL Opc NIL NIL 
13. 
99/ 
7299 
MARIMUTHU/M 60 9700 58 34 2 9200 70 42 2 20 34 12 20 11.0 12.0 NIL NIL Opc NIL NIL Opc NIL NIL 
14. 
544/ 
4892 
PAPATHI/F 59 9100 57 39 4 9400 57 38 5 12 13 10 18 10.0 13.4 NIL NIL Opc NIL NIL Opc NIL NIL 
15. 
545/ 
4907 
SHANKAR/M 35 9700 59 43 5 9700 69 33 4 5 13 8 18 12.6 14.0 NIL NIL Opc NIL NIL NIL NIL NIL 
16. 
932/ 
9669 
DHARANI/M 72 8900 55 39 6 9000 60 40 3 44 85 18 32 9.0 11.0 NIL NIL Opc NIL NIL Opc NIL NIL 
17. 2/363 VEERAPPAN/M 40 10000 54 32 4 10200 62 42 4 10 25 10 20 11.0 13.0 NIL NIL Opc NIL NIL NIL NIL NIL 
18. 
549/ 
4971 
VIJAYALAKSHMI/
F 
60 6000 53 41 6 9000 60 40 3 35 80 15 30 5.0 9.0 NIL NIL Opc NIL NIL Opc NIL NIL 
19. 
437/ 
774 
USHA/F 43 8600 55 42 4 9000 60 42 3 10 18 10 12 9.2 11.5 NIL NIL Opc NIL NIL NIL NIL NIL 
20. 
977/20
15 
SARGUNAM/F 46 9100 57 38 5 9000 60 42 3 13 27 10 22 8.9 10.0 NIL NIL Opc NIL NIL Opc NIL NIL 
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DISCUSSION 
  40 cases of Eri Gunmam attended in the Post graduate department of Maruthuvam, 
Govt.Siddha Medical College, Chennai-600 106. Out of 40 cases 20 cases which had severe 
symptoms were selected for admission in the In-patient ward. In addition the remaining 20 cases 
were treated regularly in the outpatient department for about 30 days. 
  
 The patients were examined based on Siddha and as well as modern aspects and all the 
necessary investigations were made during the history taking. The results obtained from their studies 
were discussed below. 
 
Age Distribution 
 Among 40 cases 17.5% of the cases were in the age group from 21 to 30 years, 22.5% of the 
cases were from 31 to 40, and 32.5% of the patients were from 41 to 50, 12.5 % of the patients were 
from 51 to 60, 10% of the patients were from 61 to 70 and 5% of the patients were71 to 80. 
 
Sex Distribution  
 Among 40 cases 23 were male and 17 were female.  
 
Socio Economic Status  
 Among 40 cases, 80% of the cases were poor (below 5000), 15% of the cases were from 
middle (5001 to 10000) and 5% of the cases were from high income (above 10000) group. 
 
Duration of the Illness  
 In 30% of the cases the duration of illness was from 1 month to 6 months, 35% of the cases, 
the duration was from 6 months to 1 year, 25% of the cases the duration was from 1 year to 3 years, 
10% of the cases the duration was from 3 years to 5 years, none of the cases the duration of illness 
was from 5 years and above. 
 
Clinical Features  
 In this study it is observed that all the patients taken for this study had a epigastria pain 
abdominal discomfort, Heartburn, diarrhea, loss of weight as the main clinical features. 75% of them 
had pain related to food , abdominal discomfort and tenderness in abdominal region. 50% of them 
had epigastria pain, 30 % of them had heart burn and radiating pain, 20% of them had diarrhea and 
10% of them had loss of weight. 
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Diet and Habits  
 Among 40 cases, 4(10%) were Vegetarian, 20(50%) were Non-Veg, 4(10%) were smoker 
12(30%) were alcoholic. 
 
Nilam Thinai  
 Among 40 cases 87.5% of them Neithal and 12.5% of them Marutham. 
 
Paruva Kalam 
 Out of 40 cases studied 67.5% of cases encounted in Mudhuvenil Kalam, 25% cases in    
 Kar kalam,5% cases in Koothir kalam,and2.5% cases in  Ilavenil Kalam. 
 
Kalam 
 Among 40 cases 30% cases were in Vatha Kalam, 57.5% cases were in Pitha Kalam, 
and12.5% of cases were in Kabha kalam. 
 
 
Investigation 
 An the 40 casaes were under routine laboratory investigation at the time of admission and 
discharge the urine and stool analysis reveals no significant abnormalities. 
 
Blood Group 
 Among the 40 cases 24 cases were belongs to ‘O’ blood group, 13 cases were belongs to ‘A’ 
group, 2 cases were belongs to ‘B’ group and 1 case belongs to ‘AB’ group. 
 
 
Endoscopy Investigation 
Out of the 40 cases 11 cases were put to the Endoscopy study at the laboratories and in that 5 
cases were confirmed as duodenal ulcer and the remaining 6 cases were gastric ulcer. 
 
Trial Medicines  
The trial medicines was administered to all the cases selected for study. 
1. Gunmathi Choornam – 1g, 3 times/day, After meals 
2. Musumusukai Lehyam – 5gm-2 times/day, after meals 
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Both the drugs Gunmathi Choornam and Musumusukai Lehyam produced anti ulcer activity 
which was found to the significant when compared with the control. The anti ulcer activity of both 
the drugs were comparable with that of the standard drug Ranitidine which is also significant when 
compared with the control. 
The trial medicines were subjected to the Pharmacological and Bio-Chemical analysis. 
The reports of the medicines had showed significant Anti Ulcer property. All the patients 
were treated regularly with trial medicines during this study there were no complications such as 
perforation, bleeding etc., were observed in all the 40 cases.     
 
“bjhl®thj gªj kyhJ F‹k« tuhJ” 
  
 F‹k« nehæš thj« mÂfç¤J fhz¥gL«.  thj¤ij rk¥gL¤J« RitfŸ Ïå¥ò, 
òë¥ò, c¥ò. 
 
        ÌýÁ¡¾¢ ÝÃ½õ Jt®¥ò Ritahf, k© + të ój TWghL cilajhf ÏU¥ÃD«  
F‹k nehia Fz¥gL¤Jtjhš  x¥òiuæ‹ mo¥gilæš brašgL»wJ. 
 
       ÓÍÓÍì¨¸ Ïsf« Lôol× Ritahf, të + Ô ójTWghL cilajhf ÏU¥gjhš 
thj¤ij Fiw¤J F‹k nehia Fz¥gL¤J«.  vdnt, ÏJ x¥òiuæ‹  mo¥gilæš 
brašgL»wJ. 
 
  
Bio-Chemical & Microbiological analysis  
Bio-Chemical analysis shows that the trial medicines Gunmathi Choornam is having acid 
radicals such as sulphide, Phosphate, Carbonates and oxalate, basic radicals such as ferrous iron, 
Calcium.  
The Bio-Chemical analysis of Musumusukai Lehyam shows that it has acid radicals such as 
sulphide, Phosphate, Fluoride and oxalate. Basic radicals such as ferrous Iron, and calcium. 
The antimicrobial study of Gunmathi Choornam and Musumusukai lehyam shows that is 
highly sensitive against Staphylococcus aureus, Bacillus subtilis, Streptococcus faecalis, 
Pseudomonas aeruginosa, Salmonella typhi, Escherichia coli, and Candida albicans. 
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Pharmacological reports: 
 Gunmathi chooranam+ Musumusukai Lehyam in combination exhibited anti ulcer activity in 
pylonic rats model for screening anti ulcer drugs.   
 
Toxicological evaluation  
The trial drug Gunmathi Choornam & Musumusukai lehyam did not exhibit any significant 
toxicity. The drug Gunmathi Choornam and Musumusukai lehyam falls under class 4. (L.D.50>2000 
mg/kg). The animals did not show any signs of acute toxicity and behavioural changes. 
 
Bio-Statistical study 
 The both subjective and objective parameters were statistically significant. 
 Out of 40 cases 75% had improved, 25% had symptomps relieved. 
 The statistical analysis of the results obtained from the clinical study were very much 
encouraging.   
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Summary 
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SUMMARY 
The pathogenesis of  ERI  Gunnam, clinical features differential diagnosis, prognosis and 
routine treatment of ERI Gunnam mentioned in different Siddha literature were collected. 
 The pathogenesis of ERI  Gunmam resembles the pathogenesis of peptic Ulcer in this study 
modern investigation were used with a view to understand and explain the disease ERI  Gumnam 
with modern interpretations. 
 The 40 patients were examined clearly by both Siddha and modern aspects. 
 The more prone age group was between 41 to 50th year i.e. in the Pitha kalam 
 Among 40 cases the disease was found predominant among the non-vegetarians, Alcoholism 
and found frequently in people of low income group than rich persons. 
 Most of all the patients have abdominal discomfort, pain related to food, pain in the 
abdominal region, Diarrhoea, loss of weight. 
 Among the 40 cases, Maximum no of cases came from Neithal Nilam and the Paruva kalam 
does not interfere in these studies. 
 In this study most of the patients had reported to belongs to ‘O’ group advised to have regular 
diet control and physical activities, in no cases, side effects and complications were observed. 
 The preparation of the medicines are easy and economical. The effect of the medicines is 
proved powerful in greater appeals. 
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Conclusion 
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CONCLUSION 
  The Well known common Gastro intestinal disorder ERI GUNNAM was studied in all 
aspects. All the cases were treated with trail medicines GUNMATHI CHOORNAM and 
MUSUMUSUKAI  LEHYAM which was found to be free from side effects. 
 In this study the results and observation showed that 75% cases improved, 25% of the cases 
symptoms relived.      
 Pharmacological study was done for its anti ulcer activity. The results showed 
GUNMATHI CHOORNAM + MUSUMUSUKAI LEHYAM in combination exhibited 
activity. 
 The drug combination in therapeutic doses did not show evidence of toxicity in 
haematology and biochemical marker levels or liver and kidney functions. 
 The antimicrobial study proved it to be effective against various bacteria. 
 Phytochemical tests were done which showed the presence of sulphate, Phosphate, 
Carbonates, Oxalate, Ferrous, Iron, Calcium.Alkaloids, Flavonoids, Saponins, 
Glycosides, Carbohydrates, Aminoacids, Triterpenoids. 
 The preparations of the medicines are easy and economical.  The effect of the medicines is 
proved powerful in superior appeals. 
 The drug is easily edible and the patients did not complaint any difficulty in taking the 
drug. 
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ANNEXURE-I 
Preparation and 
Properties of Trial 
Medicines  
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PREPARATIONS OF THE TRIAL MEDICINES 
DRUG NAME :  GUNMATHI CHOORANAM 
LITERATURE REFERENCE: «¸ò¾¢Â÷ «ð¼Å¨½ Å¡¸¼õ Àì¸õ-98 (ÌýÁ¡¾¢ ÝÃ½õ)  
INCREDIENTS OF GUNMATHI CHOORANAM  
ºÃìÌ¸û: 
¦¸¡Ê¦ÅÄ¢§Å÷        -      3.5 ¸¢    1 ÀÄõ 
º¢Å¨¾§Å÷              -      3.5 ¸¢    1 ÀÄõ 
¸ü¸¼¸º¢í¸¢            -    10.5 ¸¢    3 ÀÄõ 
¾¢ôÀ¢Ä¢                    -     7.0 ¸¢    2 ÀÄõ 
µÁõ                       -    14.0 ¸¢    4 ÀÄõ 
ÍìÌ                       -   10.5 ¸¢    3 ÀÄõ 
¦ÀÕí¸¡Âõ                   4.0 ¸¢ 
¦ºöÓ¨È 
Ó¾Ä¢Ãñ¨¼Ôõ À¡Ä¢ø Íò¾¢ ¦ºöÐ ¦¸¡ñ§¼ý, À¢ý þÊòÐ ÝÃ½õ ¦ºöÐ ¦¸¡ñ§¼ý. 
«Ç×: 
´Õ ¡Wôm. 
¯ñÏõ Ó¨È 
¦¿ö, §¾É¢ø ¦¸¡ûÇ- Å¡¾ ¯¼ø ¯ûÇÅ÷¸û. 
¸¡Ä «Ç×: 20 ¿¡ð¸û 
ÔU«nehŒfŸ:   F‹k«, ºò¾¢ F‹k«, ÅÂ¢üÚ þº¢× ÔU«.  
 
PROPERTIES OF INREDIENTS IN TRIAL DRUGS: 
1. ùLô¥úY- : PLUMBAGO ZEYLANCIA 
 Family : Plambaginacia 
 ÑûY : Lôol×,  
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
ùTôÕ ÏQm 
 KÓúU ®l×Ú§ KÓ¡u\ ÏuUùUhÓm 
 SôÓR²p úULWQm SôPôÕ - UôÓLú[ 
 LôÓR²p ê-ûLûV LôQôUúX]ûXÅo 
 Åh¥-Úk §mØû\ùNn ªu 
   -ÏQTôPm ê-ûL YÏl× TdLm Gi.271 
ùTôÚs : Gi YûL ÏiUm ¾Úm 
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2. £YûR úYo : (IPOMEA TURPETHUM) 
 Family : Convulaceae 
 ÑûY : ûLl×, 
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
 
ùTôÕ ÏQm 
 LôWØPu ûLl×m EiPôe LôQ G-®PjûR 
 TôWA]t ÏuUjûR Tt\ßdÏm - Tô¬p 
 ùR¬gÑûWjúRôm úT§RÚk úRùUô¯úV 
 LÚg£YûR LkRmAÕ Lôi 
   -ÏQTôPm ê-ûL YÏl× TdLm Gi. 99 
 
ùTôÚs : £YûR úYûW Ñj§L¬jÕ ùTô¥jÕ RW G¬ÏuUjûRl úTôdÏm. 
 
3. LoLPL £e¡ : (RHUS SUCCEDENA) 
 Family : Anacardiacea 
 ÑûY : ÕYol× 
 RuûU : ùYlTm 
 ©¬Ü : Lôol×  
 
ùTôÕ ÏQm 
 êX®WjRe LÓl× úUô§WjR ©jReLôp 
 úUp APÚmúUL®WQ ùYlúTô - PôXj 
 ÕÓeLôe ùLô§l× Ußk úRôûL UP UôúR 
 LÓdLô«u éûY LÚÕ 
   -ÏQTôPm ê-ûL YÏl× TdLm Gi.  165 
 
ùTôÚs : ªÏkR ÕYolûT EûPVRôp Es CWQeLû[ Btßm. 
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4. §l©- : PIPER LONGUM 
 Family : Piperaceae 
 ÑûY : C²l× 
 RuûU : ºRm 
 ©¬Ü : C²l× 
 ùNnûL : ALhÓYôVLt± 
 
ùTôÕ ÏQm 
 CÚUp ÏuUm CûWl× LVl©¦ 
 Dû[TôiÓ Nk¨VôNm AúWôNLm 
 ùTôÚUp FûR £Wl©¦ êofûN úSôn 
 é¬d ÏgNX úRôPm ©-NØm 
 YÚUX ùTÚdúLôÓ UúLôRWm 
 YôRm B§Øj úRôPu ÑWeÏ°o 
 ùTÚUûXl×¬ úUL ©PLØm 
 úTÚk §l©- úTWeÏ ÏûWdLúY 
   -ÏQTôPm ê-ûL YÏl× TdLm Gi.  368 
ùTôÚs : ÏuUm, TôiÓ, AúWôNLm, ¡ÚªúSôn úTôÏm 
 
5. KUm : CARUM CAPTICUM 
 Family : Umbelliferac 
 ÑûY : Lôol× 
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
 ùNnûL : ALhÓYôVLt±, AÝLXLt±, ÕYol©, T£j¾ çi¥ 
   C£YLt±, (antispasmatic) 
ùTôÕ ÏQm 
 ºRÑWe LôNg ùN¬Vô UkRm ùTôÚUp 
 úT§«ûWfNp LÓl× úTWôUm - K§ÚUp 
 TpùXôÚ TXêXm TLªûY úSôùVu ùNÙúUôo 
 ùNôpùXôÓúTôm KUùU] ùNôp 
   ÏQTôPm ê-ûL YÏl× TdLm Gi.  119 
ùTôÚs : ùN¬Vô UkRm, Y«tßl ùTôÚUp, úT§, ÏP-ûWfNp, Yô«tL¥ Tt±V Y- úTôÏm. 
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6. ÑdÏ : ZINGIBER OFFICINALIS 
 Family : Zingiberaceae 
 ÑûY : ûLl×, 
 RuûU : ùYlTm 
 ©¬Ü : C²l× 
 ùNnûL : T£jçi¥, ALhÓYôVLt± 
 
ùTôÕ ÏQm 
 ãûX UkRm ùSgùN¬l× úRôPm HlTm AZûX 
 êXm CûWl©ÚUp êdÏ¿o - YôXLT 
 úRôPU§ NôWk ùRôPoYôR ÏuUm ¿oj 
 úRôPm BUm úTôdÏg ÑdÏ 
   ÏQTôPm ê-ûL YÏl× TdLm Gi. 337 
ùTôÚs : Y«tßY-, ùSgùN¬Ü, HlTm, ÏuUm, Y«tû\l Tt±V úSônLs ¾Wm. 
 
7. ùTÚeLôVm : FERULA ASAFOETIDA 
 Family : Apiclceac 
 ÑûY : ûLl× 
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
ùTôÕ ÏQm 
 RkRúYRRkR êXjùRÝm ©¦ 
 NÚYLô[m ®Úf£Le ¸PmUô 
 UkRYôRm ERôYojRm ApÏpúSôn 
 UôoTQeLhP ÏuUm UúLôRWm 
 EkÕ ùLolTj§u ®j§Wf ãûXfão 
 E§Wéf£ £úXjÕUjRßm Y- 
 YkRùUn LÓl úTô¥ûY ØtßúU 
 UôÙSôÛSt LôVe ¡ûPd¡ú] 
   ÏQTôPm ê-ûL YÏl× TdLm Gi.  508 
ùTôÚs : GiYûL ÏuUm ãûX, ¡Úª, AºWQm úTôÏm. 
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PREPARATIONS OF THE TRIAL MEDICINES 
DRUG NAME :  MUMUSUKAI LEHYAM 
LITERATURE REFERENCE: 
 «Û§À¡¸ ¨Åò¾¢Â ¿Å½£¾õ Àì¸õ - 82. (1139.ÓÍÓÍì¨¸ þÇ¸õ) 
INCREDIENTS OF  MUMUSUKAI LEHYAM 
ÓÍÓÍì¨¸ º¡Ú                    -        1/2 ÀÊ 
¦ÅøÄõ                                  -        3 ÀÄõ. (105 ¸¢Ã¡õ) 
§Áüò§¾¡ø º£Å¢Â ÍìÌ           -        1 ÀÄõ. (35 ¸¢Ã¡õ) 
Á¢ÇÌ                                     -        1 ÀÄõ. (35 ¸¢Ã¡õ) 
«¡¢º¢ò ¾¢ôÀ¢Ä¢                       -        1 ÀÄõ. (35 ¸¢Ã¡õ) 
²Ä¡¢º¢                                    -        1 ÀÄõ. (35 ¸¢Ã¡õ) 
¿üº£Ã¸õ                                 -        1 ÀÄõ. (35 ¸¢Ã¡õ) 
¦ºöÓ¨È 
 ÑdûL úUp úRôp º®dùLôiÓ ©u ARàPu ª[Ï, §l©-, HX¬£, ºWLm B¡VYtû\ 
C¥jÕ Õ¦«p N-jÕd ùLôiúPu. ØÑØÑdûLf Nôt±p ùYpXjûRd LûWjÕ AÓlúTt± 
TôÏ TRj§p úUtT¥ Õû[ ùLôh¥ ¡[±  C\d¡ B±] ©u ÀeLôu Tôj§Wj§p ûYjÕ GhÓ 
Sôs Rô²V ×Pm ûYjÕ GÓjÕ Tj§Wl TÓj§d ùLôiúPu. 
A[Ü -  5 ¡Wôm, CÚúYû[  
¾Úm úSôn : G¬ÏuUm 
1. ØÑØÑdûL : BROYONIA SCABRA 
 Family : Cucurbitaceae 
 ÑûY : ÕYol× 
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
ùTôÕ ÏQm 
 LkRm TWÜL° N°Ùm ×I ®PØm  
 UkRm ùTß®ÓØm Yôk§LÞm - AkRU 
 ùTÚÏÚeÏd ¡fãÓm ©jRØªÚeLô 
 §ÚÏWe¡túLRôu 
   ÏQTôPm ê-ûL YÏl× TdLm Gi.  561 
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2 . ù Y p X m :  SACCHARUM OFFICINARUM 
 Family : Poaceace 
         ÑûY    :      C²l×,  
 RuûU : ºRm 
 ©¬Ü :  C²l× 
 ùNnûL : AÝLXLt±, Es[ZXôt±, EPp EWUôd¡ 
 
ùTôÕ ÏQm 
 ÏuU ©jRm úTôdÏU§ úLôûZRû] ÙiPôdÏm 
 ÕuUXjÕh ¸PjûR úRôtß®dÏm - SuûU úTôp 
 ùUpXUÕ ¿ûW ®û[®dÏm UôUÕW 
 ùYpXùU] SôÞm ®[m× 
ÏQTôPm ê-ûL YÏl× TdLm Gi.  166 
ùTôÚs : ÏuUjûRl úTôdÏm 
3. ÑdÏ : ZINGIBER OFFICINALIS 
 Family : Zingiberaceae 
 ÑûY : ûLl×, 
 RuûU : ùYlTm 
 ©¬Ü : C²l× 
 ùNnûL : T£jçi¥, ALhÓYôVLt± 
ùTôÕ ÏQm 
 ãûX UkRm ùSgùN¬l× úRôPm HlTm AZûX 
 êXm CûWl©ÚUp êdÏ¿o - YôXLT 
 úRôPU§ NôWk ùRôPoYôR ÏuUm ¿oj 
 úRôPm BUm úTôdÏg ÑdÏ 
   ÏQTôPm ê-ûL YÏl× TdLm Gi.  
ùTôÚs : Y«tßY-, ùSgùN¬Ü, HlTm, ÏuUm, Y«tû\l Tt±V úSônLs ¾Úm. 
4 . ª [ Ï  :  PIPER NIGRUM 
 Family : piperaceac 
 ÑûY : ûLl×, Lôol×  
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
ùNnûL : ALhÓYôVLt± (Carminative) 
ùTôÕ ÏQm 
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 ºRÑWm TôiÓ £úXjUe ¡Wô¦ ÏuUm 
 YôRm AÚ£ ©jRm UôêXm - KÕ Nu² 
 ATvUôWm APuúULm LôNªûY 
 SôNe L±ª[¡]ôp 
  ÏQTôPm ê-ûL YÏl× TdLm Gi.  761 
ùTôÚs : ÏuUm, YôÙ, ÑûY«uûU, ùN¬VôûU CûY úTôÏm. 
 
5. §l©- : PIPER LONGUM 
 Family : Piperaceae 
 ÑûY : C²l× 
 RuûU : ºRm 
 ©¬Ü : C²l× 
 ùNnûL : ALhÓYôVLt± 
ùTôÕ ÏQm 
 CÚUp ÏuUm CûWl× LVl©¦ 
 Dû[TôiÓ Nk¨VôNm AúWôNLm 
 ùTôÚUp FûR £Wl©¦ êofûN úSôn 
 é¬d ÏgNX úRôPm ©-NØm 
 YÚUX ùTÚdúLôÓ UúLôRWm 
 YôRm B§Øj úRôPu ÑWeÏ°o 
 ùTÚUûXl×¬ úUL ©PLØm 
 úTÚk §l©- úTWeÏ ÏûWdLúY 
   ÏQTôPm ê-ûL YÏl× TdLm Gi.  368 
ùTôÚs : ÏuUm, TôiÓ, AúWôNLm, ¡ÚªúSôn úTôÏm 
 
6 . H X ¬ £  :  ELETARIA EARDAMUM 
 Family : Zingi Beraceace 
 ÑûY : Lôol× 
 RuûU : ùYlTm 
 ©¬Ü : Lôol× 
ùNnûL : ALhÓYôVLt±, ùYlTØiPôd¡, T£jçi¥ 
ùTôÕ ÏQm 
 ùRôiûP YônLÜs RôÛ ÏÕeL°p 
 úRôußm úSôn A§NôWm TuúULjRôp 
 EiûPúTôp GÝe Lh¥ ¡¬fNWm 
 TiûP ùYdûL ®jRôL úSôn LôNØm 
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 TôÝgúNôUm ©¦ ®kÕ ShPm Es 
 AhûPÂû[ Yu©jRm CûYdùLpXôm 
 BXUôeLUr HXUÚkúR 
 ÏQUôPm ê-ûL YÏl× 
  ÏQTôPm ê-ûL YÏl× TdLm Gi.  114 
ùTôÚs : Yôk§, ©jRúSôn, Y«tß ©¦Ls ¾Úm. 
  
 
7. Óuf«  : Cuminum cyminum 
 Family  : Umbliferaceae 
 Rit  : fh®¥ò, Ïå¥ò 
 j‹ik : j£g«,  ÃçÎ :   Ïå¥ò 
            brŒif  : mf£L thŒ tf‰¿ 
    gÁ¤Ô¤ö©o 
    Jt®¥Ã 
    bt¥gK©lh¡» 
Fz«: 
 Ã¤jbkD kªÂçia¥ Ã‹d¥ gL¤Âat‹ 
 r¤JUit  Í‰JwªJ rhÂ¤J k¤jbdD« 
 uhridÍ   Ûbt‹W  e©ig¥  gy¥gL¤Â 
 nghrdF  lhçbrÍ« nguh   (nju‹ bt©gh) 
  
 “thªÂ aUÁF‹k«  thŒnehŒÕ  èfäiu¥ 
 ng‰¿Ukš fšyil¥Ã  yhŠrdK£ - nr®ªjf«kš 
 MrdL  ghçbaD« mªj¡ »ufâÍ« 
 nghrdF ghçÍ©z¥  ngh«.  
 “Óuf¤ij¥ bgho¤J bt©bzæš  
 bfhL¡f vçF‹k« nghF«”. 
                                                                                  Fzghl« - _èif tF¥ò  g.v©. 460 
 
       ùTôÚs :  Ô¡F‰w¤ij j‹åiy¥gL¤Â, tæ‰¿‹  kªj¤ij¥ ngh¡», gÁia c©lh¡», 
czit¢ brç¡FkhW brŒÍ«. 
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ANTIMICROBIAL ACTIVITY OF MUSUMUSUKAI LEGIUM AND GUNMATHI 
CHOORANAM 
Introduction 
 The development of bacterial resistance to presently available antibiotics has necessitated the search 
for new antibacterial agents11. The Gram-positive bacteria such as Staphylococcus aureus are mainly 
responsible for postoperative wound infection, toxic shock syndrome and food poisoning. The Gram-negative 
bacterium such as E. coli is present in human intestine and causes lower urinary tract infection, coleocystis or 
septicemia. The Gram positive and Gram-negative bacteria can be inhibited by antibiotics, either by blocking 
the protein synthesis or peptidoglycan synthesis in bacterial cell wall. The indiscriminate use of chemical 
pesticides has given rise to serious environmental pollution, genetic resistance of pests, toxic residues in 
stored products and hazards from handling etc. Therefore, there is a need to develop safe pesticides which are 
effective, biodegradable, broad-spectrum of activity and do not leave any harmful effect on environment. In 
order to identify such a drug an attempt has been made with Musumusukai Legium and Gunmathi chooranam-
a siddha drug. 
Drug Material: 
 Musumusukai Legium and Gunmathi chooranam were collected from Chennai. Tamil nadu, 
India. Quality was identified and analysed in the department of medicine, Anna hospital, Govt siddha 
medical college, Arumbakkam, Chennai. 
Preparation Of stock solution: 
 For the preparation of various concentrations of stock solutions of the siddha drugs 
Musumusukai Legium and Gunmathi chooranam were used in the present study. it was dissolved 
separately with 50 ml of DMSO under reduced pressure. The condensed supernatant was kept at 4 ºC 
prior to test. 
 
Test microorganisms: 
 Strains, including fungi and bacteria were obtained from Persian Type Culture Collection 
(PTCC). The microorganisms used in the present study include Staphylococcus aureus, Bacillus 
subtilis, Streptococcus faecalis, Aspergillus niger, Escherichia coli, and Candida albicans. 
 
    
110 
 
Experimental 
 Suitable strains of above-mentioned microorganisms were procured from the microbiology laboratory 
of our institute. Antibacterial and antifungal activities were studied by agar well plate method. The zone of 
inhibition of the Musumusukai Legium and Gunmathi chooranam was performed at concentrations of 25, 50 
and 100 mcg/ml of the fractions in dimethyl sulphoxide (DMSO). Ciprofloxacin (5 mg/ml) and Clotrimazole 
(25 mg/ml) were used as reference controls for the antibacterial and antifungal studies, respectively. Solvent 
control (only DMSO) was also maintained throughout the experiment.  
Results And Discussion 
 The Musumusukai Legium was found to be more potent than the Gunmathi chooranam. Zone of 
inhibition study reveals that both Musumusukai Legium and Gunmathi chooranam showed antibacterial and 
antifungal activity in a dose dependant manner and was comparable with the standard drugs. The results also 
reveal that both the drugs were more active against Streptococcus faecalis and less active against Basillus 
subtilis. 
References 
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PHYTO - CHEMICAL ANALYSIS 
CHEMICAL ANALYSIS OF TRIAL MEDICINES  
Preperation of Sodium Carbonate extract 
 
 2gm of Trial medicines Gunmathi choornam – drug – I and Musumusukai Lehyam-drug-
II are weighed accurately and mixed with 5gm of sodium carbonate taken in a 100ml beaker and 
20ml of distilled water is added. The solution is boiled for 10 minutes, coold and then filtered. The 
filterate is called sodium Carbonate extract.  
S. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
  Drug I Drug II Drug I Drug II 
1. TEST FOR ACID RADICALS     
a) Test for Sulphate 
2 ml of the above prepared extract 
is taken in a test tube.  To this add 2 
ml of 4% Ammonium oxalate 
solution. 
White 
precipitate 
is obtained 
White 
precipitate 
Presence of 
sulphate  
Presence of 
sulphate  
b) 2 ml of extract is added with 2 ml 
of dilute Hydrocholoric acid until 
the effervescence ceases off.  Then 
2 ml of Barium chloride solution is 
added. 
Present 
 
 
Present Present Present 
2. Test for Chloride 
2 ml of extract is added with dilute 
Nitric acid till the effervescence 
ceases.  Then 2 ml of silver Nitrate 
solution is added. 
No white 
precipitate  
No white 
precipitate  
Absence of 
Chloride  
Absence of 
Chloride 
3. Test for Phosphate 
2 ml of the extract is treated with 2 
ml of Ammonium Molybdate 
solution and 2 ml of concentrated 
Nitric Acid. 
yellow  
precipitate 
is formed 
yellow  
precipitate 
is formed 
Presence of 
phosphate  
Presence of 
phosphate 
4. Test for Carbonate 
2 ml of the extract is treated with 2 
ml of  Magnisium Sulphate 
solution. 
Effervesce
nce formed  
Effervesce
nce is  
formed 
Presence of 
Carbonate  
Presence of 
Carbonate  
5. Test for Sulphide 
1 gm of the substance is treated 
with 2 ml of concentrated 
Hydrocholric acid 
Absent  Absent Absent Absent 
6. Test for Nitrate 
I gm of the substance is heated with 
copper turnings and concentrated 
Suophuric acid and viewed the test 
tube vertically down. 
Absent  Absent  Absent Absent  
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7a. Test for Fluoride and Oxalate 
2 ml of the extract is added with 2 
ml of dilute Acetic acid and 2 ml of 
Calcium Chloride solution and 
heated. 
Absent  Present Absent  Present 
b. 5 drops of clear solution is added 
with 2 ml of dilute sulphuric acid 
and slightly warmed.  To this, 1 ml 
of dilute Potassium Permanganate 
solution is added. 
Present Present Present  Present  
8. Test for Nitrite 
3 drops of the extract is placed on a 
filter paper.  On that, 2 drops a 
Acetic Acid and 2 drops of 
Benzidine solution is placed. 
Absent  Absent Absent Absent  
9. Test for Borate 
2 pinches of the substance is made 
into paste by using Sulphuric acid 
and Alcohold (95%) and introduced 
into the blue flame. 
Absent  Absent Absent Absent  
II. TEST FOR BASIC RADICALS 
 
10. Test for lead 
2 ml of the extract is added with 2 
ml of Pottassium lodide solution 
 
Absent  Absent Absent Absent  
11a Test for Copper 
One pinch of substance is made 
into paste with concentrated 
Hydrochloric acid in a watch glass 
and introduced into the non 
luminous part of the flame. 
Absent  Absent Absent Absent  
b. 2ml of the extract is added with 
excess of Ammonia solution 
Absent  Absent Absent Absent  
12. Test for Aluminium 
To the 2nd ml of extract.  Sodium 
Hydroxide solution is added in 
drops to excess. 
Absent  Absent Absent Absent  
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13a Test for Iron 
To the 2nd ml of extract, 2 ml of 
Ammonium Thiocyanate solution 
is added. 
Present  Present Present Present  
b. To the 2nd ml of extract, 2 ml of 
Ammonium Thiocyanate solution 
and 2 ml of concentrated Nitric 
Acid is added. 
Present Present Present Present 
14. Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
drops to excess. 
Absent  Absent Absent Absent  
15. Test for Calcium 
2 ml of the extract is added with 2 
ml of 4% Ammonium Oxalate 
solution. 
Present  Present  Present  Present  
16. Test for Magnesium 
To 2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absent  Absent Absent Absent  
17. Test for Ammonium 
To 2 ml of extract few ml of 
Nessler’s Reagent and excess of 
Sodium Hydroxide solution are 
added. 
Absent  Absent Absent Absent  
18. Test for Potassium 
A pinch of substance is treated with 
2 ml of Sodium Nitrite solution and 
then treated with 2 ml of Cobal 
Nitrate in 30% glacial Acetic acid. 
Absent  Absent Absent Absent  
19. Test for Sodium 
2 pinches of the substance is made 
into paste by using Hydrocholoric 
acid and introduced into the blue 
flame. 
Absent  Absent  Absent  Absent  
20. Test for Mercury 
2 ml of the extract is treated with 2 
ml of Sodium Hydroxide solution. 
Absent  Absent  Absent  Absent  
21. Test for Arsenic 
2 ml of extract is treated with 2 ml 
of silver Nitrate solution 
Absent  Absent  Absent  Absent  
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Results  
The given sample contains   
 
ACID RADICALS 
1. Gunmathi Choornam 
 Sulphate 
 Phosphate 
 Carbonate 
 Oxalates   
 
2. Musumusukai Lehyam 
 Sulphate 
 Phosphate 
 Fluoride  
  oxalate  
BASIC RADICALS 
1. Gunmathi Choornam 
 Ferrous Iron 
 Calcium 
2. Musumusukai Lehyam 
 Ferrous iron 
 Calcium 
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I Treatment for ERI Gunmam (Peptic Ulcer) 
 
  The most popular statistical tool, namely, chi-square (Good ness of fit) analysis has been 
employed to analyses the effectiveness with the help of a Hypothesis. 
 
Hypothesis: 
 There is significant improvement among the patients for the treatment of ERI Gunmam. 
 
 
 
Table of observed frequencies ‘O’ 
Symptoms  No of patients Total 
Improved 
‘O’ 
Not 
improved 
Epigastric Pain 19 1 20 
Heart burn 8 4 12 
Abdominal discomfort 26 4 30 
Diarrhea 8 0 8 
Loss of weight  3 1 4 
Total 64 10 74 
 
 
1Table of Expected frequencies “E” 
Symptoms  ‘O’ ‘E’ 
Epigastric Pain 19 17.29 
Heart burn 8 10.38 
Abdominal discomfort 26 25.95 
Diarrhea 8 6.92 
Loss of weight  3 3.46 
Total 64 64.00 
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Calculation of X2 
O E (O-E) (O-E)2 (O-E)2 / E 
19 17.29 1.703 2.900 0.617 
8 10.38 -2.378 5.654 0.544 
26 25.95 0.055 0.003 1.16593E-4 
8 6.92 1.082 1.700 0.169 
3 3.46 -0.459 0.210 0.060 
   Total 0.94 
 
Result: 
 The calculated value of X2 is = 0.94. 
 The table value of  X2 < 5% significant level. 
      As per probability level (alpha) for 4 df = 9.488.  
 
Inference: 
 Since the calculated value is less than the table value, the Hypothesis is accepted.  Hence it is 
concluded that the treatment is effective and significant. 
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MATERIALS AND METHODS 
Test Drugs 
 The following medicinal plants used in the study were collected and processed by the 
methods prescribed in standard text books of siddha medicines. 
Gunmathi chooranam and Musumusukai  lehyam  
         Were prepared by the method described in (Agathiyar Attavanai Vagadam (Page No: 98)  and 
Anuboga vaidtheya navaneetham (Page No: 82)) 
 
Gunmathi chooranam 
Drug and Preparation of Stock solution  
 The aqueous suspension of Gunmathi Chooranam was prepared in 0.5 % 
carboxymethylcellulose (CMC) solution in distilled water prior to oral administration to animals. It 
was used within seven days and stored at 8oC while for further use, freshly prepared solution was 
used. The vehicle alone served as control. All the drugs and chemicals were of analytical grade. 
Ranitidine (Osaka), Ethanol (Research lab) were used. 
Experimental animals 
 Albino rats (Wistar strain) of either sex, weighing 180-200g and Swiss albino mice (20-22g) 
of either sex were procured from animal housing facility, School of pharmaceutical Sciences, Vels 
university, Chennai. All the animals were placed in polypropylene cages in a controlled room 
temperature 22±1°C and relative humidity of 60-70% in animal house. The animals were maintained 
on standard pellet diet (Sai meera foods Pvt limited, Bangalore, India) and water ad libitum. They 
were acclimatized to laboratory condition for seven days before commencement of the experiment. 
Ethical clearance was obtained from Institutional Animal Ethical Committee. 
Acute oral toxicity study 
 Acute oral toxicity study of Gunmathi Chooranam was carried out in Swiss albino mice of 
both sexes (20-22 g) according to OECD guidelines no 423. Gunmathi Chooranam at different doses 
up to 2000mg/kg, p.o. was administered and animals were observed for behavioral changes, any 
toxicity and mortality up to 48 h.  
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ASSESSMENT OF ANTI-ULCER ACTIVITY 
Pyloric ligation induced gastric ulceration.  
 Albino rats of either sex were divided into five groups of six animals each. Animals were 
fasted for 24 h before the study, but had free access to water.  
Group I: treated with vehicle alone (2ml/kg, p.o.) and was kept as control.  
Group II: treated with Ranitidine (100mg/kg, p.o.) and was kept as standard.  
Group III: treated with the Gunmathi Chooranam (125mg/kg, p.o.).  
Group IV: treated with the Gunmathi Chooranam (250mg/kg, p.o.).  
Group V: treated with the Gunmathi Chooranam (500mg/kg, p.o.). 
 After 1h of drug treatment, they were anaesthetized with the help of anesthetic ether; the 
abdomen was opened by a small midline incision below the xiphoid process. Pyloric portion of the 
stomach was slightly lifted out and ligated according to method of Shay et al., avoiding traction to 
the pylorus or damage to its blood supply. The stomach was replaced carefully and the abdominal 
wall was closed by interrupted sutures. Rats were sacrificed by an over dose of anaesthetic ether after 
four hours of pyloric ligation. The abdomen was opened, cardiac end of the stomach was dissected 
out and the contents were drained into a glass tube. The volume of the gastric juice was measured 
and centrifuged at 2000 rpm for 10 min. From the supernatant, aliquots (1 ml of each) were taken for 
the determination of pH, total and free acidity. The inner surface of free stomach was examined for 
gastric lesions.  
Determination of PH 
 An aliquot of 1ml gastric juice was diluted with 1ml of distilled water and pH of the solution 
was measured using pH meter. Determination of total acidity 
 
                An aliquot of 1ml gastric juice diluted with 1ml of distilled water was taken into a 50ml 
conical flask and two drops of phenolphthalein indicator was added to it and titrated with 0.01N 
NaOH until a permanent pink colour was observed. The volume of 0.01N NaOH consumed was 
noted.  
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                   The total acidity is expressed as meq./l by the following formula: 
 
n Χ 0.01 Χ 36.45 Χ 1000 
                   Where n is volume of NaOH consumed, 36.45 is molecular weight of NaOH, 0.01 is 
normality of NaOH, 1000 is the factor (to be represented in litre)  
 
Determination of free acidity 
 Instead of phenolphthalein indicator, the Topfer's reagent was used. Aliquot of gastric juice 
was titrated with 0.01N NaOH until canary yellow colour was observed. The volume of 0.01N 
NaOH consumed was noted. The free acidity was calculated by the same formula for the 
determination of total acidity. 
Macroscopic evaluation of stomach 
 The stomach was opened along the greater curvature, rinsed with saline to remove gastric 
contents and blood clots and examined by a Χ5 magnifier lens to assess the formation of ulcers. The 
number of ulcers were counted. Ulcer scoring was undertaken according to Vogel et al.   
Ulcer index was measured by using following formula according to vogel et al.  
 
UI=UN+US+UPΧ10−1 
UI= Ulcer Index; UN= Average number of ulcers per animal; US =Average number of severity 
score; UP=percentage of animals with ulcers 
Percentage inhibition of ulceration was calculated as below: 
      (Ulcer index Control-Ulcer index Test)  
% Inhibition of Ulceration = ____________________________________ Χ 100 
        Ulcer index Control 
 
Ulcer score Descriptive /observation 
0 Normal coloured stomach 
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0.5 Red colouration 
1.0 Spot ulcers 
1.5 Haemorrhagic streak 
2.0 Ulcers 
3.0 Perforation 
Statistical analysis 
 The results are expressed as the mean± SEM for each group. Statistical differences were 
evaluated using a One-way analysis of variance (ANOVA) followed by Dunnet's t-test. Results were 
considered to be statistically significant at P<0.05. 
 
RESULTS 
Acute oral toxicity study 
 Swiss albino mice of both the sexes treated with Gunmathi Chooranam did not show any 
behavioral changes, toxic reaction or mortality. It was found to be safe at the dose of 2000mg/kg. 
LD50 of the Gunmathi Chooranam was found to be >2000mg/kg. 
 
Pyloric ligation induced gastric ulceration 
 Effect of Gunmathi Chooranam on pyloric ligation induced ulceration is shown in table-1. 
The pyloric ligation has caused the accumulation of gastric secretions with pH 3.88±0.17 in a control 
group. The total acidity and free acidity of the gastric secretions were found to be 172±2.28 and 
115.11±0.48meq./l respectively. Pretreatment with the Gunmathi Chooranam, significantly (P<0.01) 
reduced the volume of gastric secretions 3.00±0.03, 3.51±0.03 and 3.33±0.03ml at the doses of 125, 
250 and 500mg/kg respectively. pH of the gastric fluid was significantly (P<0.05) elevated up to 
4.52±0.46 only at higher dose of the test drug.  
 In addition, total acidity and free acidity were also reduced significantly (P<0.01) in a dose 
dependant manner. Further it is observed that pyloric ligation has caused gastric ulcerations and 
pretreatment with Gunmathi Chooranam has reduced them significantly (P<0.01) in a dose 
dependent manner. In this model, percentage inhibition of ulceration was found to be 52, 64 and 66 
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at 125, 250 and 500mg/kg respectively. The gastroprotection offered by the test drug was 
comparable to that of the standard drug, ranitidine (100mg/kg). 
 
DISCUSSION 
 Although in most of the cases the etiology of the ulcers is unknown, it is generally accepted 
that they are a result of an imbalance between aggressive factors and the maintenance of mucosal 
integrity through endogenous defensive mechanisms. Pylorus ligation induced ulcers are due to auto 
digestion of the gastric mucosa and breakdown of the gastric mucosal barrier. These factors are 
associated with the development of upper gastrointestinal damage including lesions, ulcers and life 
threatening perforation and hemorrhage. Aspirin, phenylbutazone, indomethacin and some non-
steroidal anti-inflammatory drugs are also known to cause duodenal and gastric ulceration. 
Prostaglandin E2 and I2 are predominantly synthesized by the gastric mucosa and are known to 
inhibit the secretion of gastric acid and stimulate the secretion of mucus and bicarbonate.  
 Hydrophobic surfactant - like phospholipids secretion in the gastric epithelial cells is also 
stimulated by the prostaglandin. Volume of gastric secretion is an important factor in the production 
of ulcer due to exposure of unprotected lumen of the stomach to the accumulating acid. The antiulcer 
property of Gunmathi Chooranam in pylorus ligation model is evident from its significant reduction 
in free acidity, total acidity, number of ulcers and ulcer index. Gunmathi Chooranam treated animals 
significantly inhibited the formation of ulcers in the pylorus ligated rats and also decreased both the 
concentration and increased the pH, it is suggested that Gunmathi Chooranam can suppress gastric 
damage induced by aggressive factors. It is suggested that, the active compounds would be able to 
stimulate mucus, bicarbonate and the prostaglandin secretion and counteract with the deteriorating 
effects of reactive oxidants in gastrointestinal lumen. So the antiulcer activity of Gunmathi 
Chooranam may be attributed to its active principle.  
CONCLUSION 
 The results obtained in the experimental model of pylorus ligation induced ulceration method 
in rats. The Gunmathi Chooranam was found to posses remarkable ulcer protection of 68.2% at 
500mg/Kg and standard drug at 68.4%. Pylorus ligation consistently caused hemorrhagic lesions in 
the mucosa of the glandular stomach, indicating true ulcer formation as stated in histological 
findings. Pretreatment of rats with Gunmathi Chooranam prevented gastric ulcerogenesis 
significantly. But it is seemed to be less efficient than standard drug. The result of the present study 
substantiates the traditional claim that the Gunmathi Chooranam possess antiulcer activity. The 
results of the present study suggest that the Gunmathi Chooranam may be beneficial in the treatment 
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of gastric lesions. Further studies to identify the active moieties and elucidation of the mechanism of 
action are recommended. 
 
Table 1 — Effect of Gunmathi Chooranam on total and free acidity, gastric volume and ulcer 
index 
Groups Total acidity 
(mEq/l) 
Free aciditly 
(mEq/l) 
Gastric Volume 
(ml/100g) 
Ulcer index  
(% Ulcer 
protection) 
CMC control 172±2.28 115.11±0.48 2.9±0.05 1.15±0.02 
Control (Pyloric 
ligated) 
251±2.84 173.23±0.52 4.76±0.04 5.00±0.05 
Gunmathi Chooranam 
(125 mg/kg) 
176±2.12** 120.12±0.74** 3.00±0.03** 2.37±0.06** 
(52.60) 
Gunmathi Chooranam 
(250mg/kg) 
185±3.07** 148.16±0.54** 3.51±0.03** 1.79±0.05** 
(64.20) 
Gunmathi Chooranam 
(500mg/kg) 
197±2.88** 132.10±0.77** 3.33±0.03** 1.68±0.05**(66.40) 
Ranitidine (100mg/kg) 162±2.19** 123.08±0.53** 2.68±0.07** 1.25±0.05** 
(75.00) 
*P values <0.05 as compared to ligation control; Values are the mean ± S.E.M. of six rats 
/treatment. Significance *p <0.05, **p<0.01 Vs Control 
 
 
 
 
 
 
 
 
 
ACUTE AND SUB ACUTE TOXICITY STUDY OF GUNMATHI CHURNAM 
 
PRINCIPLE OF THE TEST  
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 It is the principle of the test that based on a stepwise procedure with the use of a minimum 
number of animals per step, sufficient information is obtained on the acute toxicity of the test 
substance to enable its classification. The substance is administered orally to a group of experimental 
animals at one of the defined doses. The substance is tested using a stepwise procedure, each step 
using three animals of a single sex. Absence or presence of compound-related mortality of the 
animals dosed at one step will determine the next step, i.e.; − no further testing is needed, − dosing of 
three additional animals, with the same dose − dosing of three additional animals at the next higher 
or the next lower dose level. The method will enable a judgement with respect to classifying the test 
substance to one of a series of toxicity classes.  
Preparation of animals:  
 The animals are randomly selected, marked to permit individual identification, and kept in 
their cages for at least 5 days prior to dosing to allow for acclimatization to the laboratory conditions.  
Preparation of doses:  
 In general test substances should be administered in a constant volume over the range of 
doses to be tested by varying the concentration of the dosing preparation. Where a liquid end product 
or mixture is to be tested however, the use of the undiluted test substance, i.e. at a constant 
concentration, may be more relevant to the subsequent risk assessment of that substance, and is a 
requirement of some regulatory authorities. In either case, the maximum dose volume for 
administration must not be exceeded. The maximum volume of liquid that can be administered at one 
time depends on the size of the test animal.  
 In rodents, the volume should not normally exceed 1mL/100g of body weight: however in the 
case of aqueous solutions 2 mL/100g body weight can be considered. With respect to the formulation 
of the dosing preparation, the use of an aqueous solution/suspension/emulsion is recommended 
           wherever possible, followed in order of preference by a solution/suspension/emulsion in oil 
(e.g. corn oil) and then possibly solution in other vehicles. For vehicles other than water the 
toxicological characteristics of the vehicle should be known. Doses must be prepared shortly prior to 
administration unless the stability of the preparation over the period during which it will be used is 
known and shown to be acceptable.  
Number of animals and dose levels:  
 Three animals are used for each step. The dose level used as the starting dose was selected 
from one of four fixed levels, 5, 50, 300 and 2000 mg/kg body weight. The available information 
suggests that mortality is likely at the highest starting dose level 2000 mg/kg body weight, so the trial 
or limit test was conducted. Even though there is inadequate information on the test substance, hence 
for animal welfare reasons the starting dose of 300mg/kg body weight was selected. The time 
interval between treatment groups is determined by the onset, duration, and severity of toxic signs. 
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The test substance-related mortality was not produced in animals, so further testing at the next lower 
level need not be carried out.  
OBSERVATIONS:  
 Animals are observed individually after dosing at least once during the first 30 minutes, 
periodically during the first 24 hours, with special attention given during the first 4 hours, and daily 
thereafter, for a total of 14 days, except where they need to be removed from the study and humanely 
killed for animal welfare reasons or are found dead. All observations are systematically recorded 
with individual records being maintained for each animal. Observations include changes in skin and 
fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous 
systems, and somatomotor activity and behaviour pattern. Attention was directed to observations of 
tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarised in the Humane Endpoints Guidance Document taken into consideration. Animals found 
in a moribund condition and animals showing severe pain or enduring signs of severe distress was 
humanely killed. When animals are killed for humane reasons or found dead, the time of death 
should was recorded. 
 
Body weight:  
 Individual weight of animals was determined before the test substance was administered, and 
at least weekly thereafter. Weight changes was calculated and recorded. At the end of the test 
surviving animals were weighed and humanely killed.  
 
 
Pathology:  
 All test animals were subjected to gross necropsy. All gross pathological changes were 
recorded for each animal. Microscopic examination of organs showing evidence of gross pathology 
in animals surviving 24 or more hours also was considered.  
Data and reporting:  
 All data were summarised in tabular form, showing for each test group the number of animals 
used, the number of animals displaying signs of toxicity, the number of animals found dead during 
the test or killed for humane reasons, time of death of individual animals, a description and the time 
course of toxic effects and reversibility, and necropsy findings.  
 
 
TOXICITY STUDIES OF GUNMATHI CHURNAM 
Administration of doses:  
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 Gunmathi Churanam suspended in 0.5% CMC with vigourous mixing and was administered 
to the groups of mice in a single oral dose by gavage using a feeding needle. The control group 
received an equal volume of the vehicle. Animals were fasted prior to dosing. Following the period 
of fasting, the animals were weighed and then the test substance was administered. After the 
substance has been administered, food was withheld for a further 3-4 hours. The principle of 
laboratory animal care was followed. Observations were made and recorded systematically and 
continuously observed as per the guideline after substance administration. The visual observations 
included skin changes, mobility, aggressively, sensitivity to sound and pain, as well as respiratory 
movements. They were deprived of food, but not water 16–18 h prior to the administration of the test 
suspension. Finally, the number of survivors was noted after 24 h and these animals were then 
maintained for a further 14 days and observations made daily. The toxicological effect was assessed 
on the basis of mortality.  
Test substance and Vehicle:  
 The test substance is partially soluble in water but the particle size is large and so the rapid 
settling was observed. Hence in order to ensure the uniformity in drug distribution in the medium the 
suspension was made with 0.5% CMC solution and it was found suitable for dose accuracy.  
 
Test animals and Test conditions:  
 Sexually mature either sex albino mice (28-35g) were obtained from the animal laboratory of 
the School of Pharmaceutical sciences, Vels University.  All the animals were kept under standard 
environmental condition (27±2°C).  The animals had free access to water and standard pellet diet 
(Sai meera foods, Bangalore). Mice were deprived of food but not water (16-18 h) prior to 
administration of the Gunmathi Churanam. The principles of laboratory animal care were followed 
and the Department’s ethical committee approved the use of the animals and the study design.  
 
 
 
 
 
 
REPEATED DOSE 28-DAY SUBACUTE ORAL TOXICITY STUDY OF GUNMATHI 
CHURANAM IN RATS 
Test Substance: Gunmathi Churanam 
Animal Source: Vels Animal house 
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Animals: Male and Female wistar Rats  
Age: 6-8 weeks 
Body Weight on Day 0: Males: Mean 110.25g Females: Mean 108.42g 
Acclimatization: Seven days prior to dosing. 
Veterinary examination: Prior to and at the end of the acclimatization period. 
Identification of animals: By cage number, animal number and individual marking on fur. 
Diet: Pelleted feed supplied by Sai meera foods Pvt  Ltd, Bangalore 
Water: Aqua guard portable water in polypropylene bottles ad libitum. 
Housing & Environment: The animals were housed in Polypropylene cages provided with bedding 
of husk. 
Housing temperature between 20o & 24°C,  
Relative humidity between 30% and 70%, 
Air changes 10 to 15 per hour and  
Dark and light cycle each of .12 hours. 
Justification for Dose Selection: 
 As stated in results of acute toxicity studies in wistar rats indicated that Gunmathi Churanam 
was non toxic upto the dose level of 5000 mg/kg body weight observed after 48 hours of oral drug 
treatment. On the basis of these results, the doses selected for the study was 100mg/kg, 200 mg/kg 
and 400mg/kg body weight. The oral route was selected for use because oral route is considered to 
be a proposed therapeutic route. 
 
 
Preparation and administration of dose: 
 Gunmathi Churanam was suspended in CMC in distilled water to obtain concentrations of 
200mg/ml. It was administered to animals at the dose levels of 100mg/kg, 200mg/kg and 400mg/kg 
in the dose volume of 10mL/kg. The test substance suspensions were freshly prepared every two 
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days once for 28 days. The control animals were administered vehicle only. Administration was by 
oral (gavage), once daily for 28 consecutive days. 
 
Randomization, Numbering and Grouping of Animals: 
 Six rats were in each group randomly divided into four groups for dosing up to 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior to the initiation 
of treatment. Each animal was fur marked with picric acid. The females were nulliporous and non-
pregnant. 
 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study for the 
following: 
(i) Body Weight: Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, group mean 
body weights and percent body weight gain were calculated. (Table-2) 
(ii) Food and water Consumption: The quantity of food consumed by groups consisting of six 
animals of for different doses was recorded at weekly interval. Food consumed per animal was 
calculated for control and the treated dose groups. (Table-3&4) 
(iii) Clinical signs: All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
(iv) Mortality: All animals were observed twice daily for mortality during entire course of study. 
(v) Ophthalmoscopy: The eyes of experimental animals in control as well as treated groups given 
different dose levels were examined prior to the initiation of the dosing and in 4th and the 6th week of 
the study. Eye examination was carried out using a hand slit lamp after induction of mydriasis with 
Atropine sulphate solution.  
(vi) Functional Observations: At the end of the 4th week exposure, ‘sensory reactivity’ to graded 
stimuli of different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and ‘grip 
strength’ were assessed. 
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Laboratory Investigations: Following laboratory investigations were carried out on day 29 in 
animals’ fasted over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Haematological Investigations: Haematological parameters were determined using Haematology 
analyzer. (Table-5) 
Biochemical Investigations: Biochemical parameters were determined using auto-analyzer. (Table-
6, 7 & 8) 
Urine analysis: Urine samples were collected in week 4 and in week 6 and for estimation of normal 
parameters. The estimations were performed using appropriate methodology. (Table-9) 
Necropsy: All the animals were sacrificed on day 29. Necropsy of all animals was carried out and 
the weights of the organs including liver, kidneys, adrenals, spleen, brain, heart, uterus and 
testes/ovaries were recorded. The results are shown in Table-10 . 
Histopathology: Tissue samples of organs from control and treated animals at the highest dose level 
were preserved in 10% formalin. The organs included brain, heart, kidneys, liver, lungs, spleen, 
stomach, and uterus of the animals were preserved they were subjected to histopathological 
examination. 
Statistical analysis: findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way Anova followed by 
dunnet’t’ test using a computer software programme -INSTAT-V3 version. 
 
RESULTS: 
Clinical signs: 
Animals were not shown any significant toxic clinical signs during the dosing period of 28 days. 
Mortality: All animals from control and all the treated dose groups survived throughout the dosing 
period of 28 days and it was found no animal dead after 28 days of treatment in high dose. 
Body weight: Results of body weight determination of animals of control and different dose groups 
exhibited comparable body weight gain throughout the dosing period of 28 days. 
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Food consumption: During dosing period, the quantity of food consumed by animals from different 
dose groups was found to be comparable and normal with that of control animals. 
Ophthalmoscopy: Ophthalmoscopic examination of animals in control and test product– treated 
groups did not reveal any major and remarkable abnormality. 
Functional Observations: These tests conducted on the experimental animals at termination and 
recorded did not reveal any abnormalities.  
Urine analysis: Urine analysis data (Table 9) of control group and treated group of animals 
determined in week 4 and animals in week 6 did not reveal any abnormalities.  
Organ Weight: Group Mean Relative Organ Weights (%of body weight) are recorded in Table-10. 
Comparison of organ weights of treated animals with respective control animals on day 29 was 
found to be comparable.  
Necropsy: Gross pathological examination of animals in control as well as the treated groups did not 
reveal any abnormalities.  
Haematological investigations: The results of haematological investigations (Table 5) conducted on 
day 29, revealed following significant changes in the values of different parameters investigated 
when compared with those of respective controls; However, the increase or decrease in the values 
obtained was within normal biological and laboratory limits. A slight increase in total RBC count 
values were obtained for animals in the dose group of 200 and 400 mg/kg (P<0.05). Decreased 
values of platelets (P<0.05) were observed for animals in dose groups administered 400mg/ kg body 
weight of Gunmathi Churanam sacrificed on day 29. 
Biochemical Investigations: Results of Biochemical investigations conducted on days 29 and 
recorded in Table 6,7,8 revealed the following significant changes in the values of different 
parameters studied when compared with those of respective controls; however, the values obtained 
were within normal biological and laboratory limits. Blood Urea Nitrogen showed reduced levels in 
animals in 400mg/kg dose group (P<0.05), Protein level is elevated in animals of 200 and 400 mg/kg 
dose group (P<0.05). Aspartate Amino transferase levels slightly decreased in animals of 200 and 
400mg/kg group (P<0.01).  
 
DISCUSSION: 
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1) All the animals from control and all the treated dose groups up to 400 mg/kg survived throughout 
the dosing period of 28 days. 
2) No signs of major or significant intoxication were observed in animals from lower to higher dose 
groups during the dosing period of 28 days. 
3) Animals from all the treated dose groups exhibited comparable body weight gain with that of 
controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable throughout the 
dosing period of 28days. 
5) Ophthalmoscopic examination, conducted prior to and at the end of dosing period on animals from 
control and all the treated dose groups did not reveal any abnormality. 
6) Haematological analysis conducted at the end of the dosing period on day 29, revealed no 
significant abnormalities attributable to the treatment. 
7) Biochemical analysis conducted at the end of the dosing period on day 29, revealed no remarkable 
abnormalities attributable to the treatment. 
8) Functional observation tests conducted at termination revealed no abnormalities. 
9) Urine analysis, conducted at the end of the dosing period in week 4 and at the end of recovery 
period in week 6, revealed no abnormality attributable to the treatment. 
10) Organ weight data of animals sacrificed at the end of the dosing period was found to be 
comparable with that of respective controls. 
11) Gross pathological examination did not reveal any abnormality. 
12) Histopathological examination did not reveal any abnormality. 
CONCLUSION: 
 Based on these findings, no toxic effect was observed upto 400mg/kg of Gunmathi 
Churanam treated via oral route over a period of 28 days. So, it can be concluded that the Gunmathi 
Churanam can be prescribed for therapeutic use in human with the dosage recommendations of upto 
400mg/kg. body weight p.o. 
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Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 5 + - - + - + - - - - - - - - - - - - - - 
2 50 + - - + - + - - - - - - - - - - - - - - 
3 300 + - - + - + - - - - - - - - - - - - -  - 
4 2000 + - - + - + + - - - - - + - - - - - - - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. 
Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle 
relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 
19. Respiration 20. Mortality 
 
 
Table 2. Body wt (g) of albino rats exposed to Gunmathi Churnam for 28days. 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 112.545.05 110.566.00 114.825.25 118.058.11 123.005.69 
100 117.076.31 119.215.15 122.195.76 125.6410.00 126.566.08 
200 114.265.44 118.136.88 121.086.15 124.187.14 127.378.14 
400 112.137.27 115.625.34 118.126.98 121.026.33 124.517.32 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 3. Food (g/day) intake of albino rats exposed to Gunmathi Churnam for 28days. 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 44.052.99 44.882.15 46.142.12 45.082.55 47.523.21 
100 42.272.78 45.332.46 46.462.66 49.102.96 48.153.00 
200 40.382.19 42.042.59 44.622.47 45.863.16 46.003.08 
400 43.612.56 45.282.83 46.112.85 45.172.00 45.003.13 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
Table 4. Water (ml/day) intake of male and female albino rats exposed to Gunmathi Churnam 
for 28days. 
 
Dose 
(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 55.002.89 52.073.38 55.283.18 52.373.10 51.203.29 
100 52.182.46 50.223.00 45.234.00 46.153.04 40.552.88 
200 49.742.88 40.163.78 40.873.39 42.102.98 41.103.27 
400 52.313.50 54.673.05 51.263.88 48.203.10 45.233.65 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 5. Hematological parameters after 28days treatment with Gunmathi Churnam in rats. 
Parameter Control 100 mg/kg 200 mg/kg 400 mg/kg 
Red blood cell 
(mm3) 
8.060.75 7.980.64 8.150.59 9.030.52 
HB (%) 14.120.32 15.120.39 14.560.42 15.000.48 
Leukocyte 
(x106/mL) 
10228115.96 10385207.24 10305234.15 10366219.34 
Platelets/ul 144243.19 139638.24 113732.22 99532.46 
MCV (gl) 55.465.28 53.154.27 55.045.27 56.144.86 
DLC (%) 
N 5.661.31 5.231.27 4.880.96 5.153.79 
L 95.302.98 90.803.51 93.283.62 96.323.88 
M 2.00.33 2.00.38 2.240.28 2.320.26 
E 1.000.00  1.00.22  1.00.11 1.000.11 
B 0 0 0 0 
ESR(mm) 100 100 100 100 
PCV 46.322.56 45.242.14 45.003.00 45.643.22 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 6. Effect of treatment with Gunmathi Churnam biochemical parameters. 
LFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total Bilirubin (mg/dL) 0.2090.05 0.2120.06 0.2180.05 0.2150.04 
Bilirubin direct (mg/dL) 0.10.04 0.10.05 0.10.04 0.10.05 
Bilirubin 
indirect(mg/dL) 
0.100 0.100 0.100 0.100 
ALP (U/L) 382.3410.16 374.2112.32 286.3810.30 294.112.32 
SGOT (U/L) 168.246.21 160.676.58 156.385.80 154.016.57 
SGPT(U/L) 46.42.34 44.83.20 45.082.58 46.624.19 
Total Protein(g/dl) 10.021.30 9.170.30 8.520.27 9.120.46 
Albumin(g/dl) 3.210.25 3.190.24 3.460.33 3.220.12 
Globulin(g/dl) 6.020.18 5.180.26 4.980.21 4.860.30 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
 
Table-7 RFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Urea(mg/dL) 55.421.63 54.343.56 55.22.14 53.881.36 
Creatinine (mg/dL) 0.780.05 0.760.05 0.780.06 0.760.05 
Uric acid (mg/dL) 1.60.12 1.60.18 1.60.16 1.60.14 
Na m.mol 140.785.26 141.25.00 141.125.22 141.105.00 
K m.mol 20.202.88 19.451.68 20.01.46 20.152.02 
Cl m.mol 100.054.24 101.205.21 99.884.82 101.045.16 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
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Table-8. Lipid Profile 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total cholestrol(mg/dL) 40.682.57 41.122.46 40.123.20 42.053.00 
HDL(mg/dL) 13.021.44 13.251.77 13.001.45 13.202.31 
LDL(mg/dL) 42.002.83 44.053.61 42.313.90 43.283.32 
VLDL(mg/dl) 16.382.62 15.822.34 16.001.64 15.061.24 
Triglycerides (mg/dl) 88.243.00 85.162.22 86.233.24 88.442.78 
TC/HDL ratio (g/dl) 3.560.24 3.800.28 3.750.30 3.530.25 
Blood glucose(mg/dl) 125.356.78 126.904.25 126.135.66 124.112.45 
Table-9 Urine Analysis 
Parameters 
Control 100 mg/kg 200 mg/kg 400 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid Slightly cloudy Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen 
Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
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Table 10. Effect of oral administration of a Gunmathi Churnam on organ weight 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Liver (g) 5.200.17 5.320.15 4.920.12 5.150.18 
Heart (g) 0.620.04 0.620.05 0.590.04 0.580.04 
Lung (g) 1.490.06 1.440.14 1.360.24 1.520.15 
Spleen (g) 0.650.05 0.680.04 0.660.04 0.650.05 
Ovary (g) 1.690.14 1.780.15 1.680.18 1.760.15 
Testes (g) 1.480.10 1.450.12 1.460.15 1.490.15 
Brain (g) 1.560.15 1.580.13 1.560.14 1.530.14 
Kidney (g) 0.730.04 0.710.04 0.700.04 0.720.05 
Stomach (g) 1.360.12 1.340.10 1.380.11 1.350.12 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01 vs control N=6. 
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Histopathology 
Antiulcer Activity of Gunmathi choornam & Musumusukai Laheam  
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ANTIULCER ACTIVITY OF MUSUMUSUKAI LEGIUM BY 
PYLORIC LIGATION METHOD IN RATS 
 
Drug and Preparation of Stock solution 
 The Musumusukai legium was soluble but solid mass settling was observed so as to get 
uniformity in concentration the solution was converted into suspension form using 2% gum acacia. 
The final stock solution for this study was 200mg/ml. 
Acute oral toxicity study 
 Acute oral toxicity study of Musumusukai legium was carried out in Swiss albino mice of 
both sexes (28-32g) according to OECD guidelines no 423.  
Antiulcer activity-Grouping and treatment 
Pyloric ligation induced gastric ulceration.  
 Albino rats of either sex were divided into five groups of six animals each. Animals were 
fasted for 24 h before the study, but had free access to water.  
Group I: treated with vehicle (2ml/kg, p.o.) and was kept as control.  
Group II: treated with Ranitidine (100mg/kg, p.o.) and was kept as standard.  
Group III: treated with the Musumusukai legium (100mg/kg, p.o.).  
Group IV: treated with the Musumusukai legium (200mg/kg, p.o.).  
Group V: treated with the Musumusukai legium (400mg/kg, p.o.). 
RESULTS 
Acute oral toxicity study 
 Swiss albino mice of both the sexes treated with Musumusukai legium did not show any 
behavioral changes, toxic reaction or mortality. It was found to be safe at the dose of 2000mg/kg. 
LD50 of the Musumusukai legium was found to be >2000mg/kg. 
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Pyloric ligation induced gastric ulceration 
 In pylorus ligation induced ulcer model a significant increase in gastric volume (4.76±0.04), 
free acid (173.23±0.52mEq/L) and total acid (251±2.84mEq/L) were noted. Standard drug ranitidine 
100mg/kg treatment has significantly reduced ulcer (0.16±0.16) (UI-1.25), gastric volume 
(2.68±0.07ml), free acid (123.08±0.53mEq/L) and total acid (162±2.19mEq/L). In pylorus ligation 
induced ulcer model both 200 and 400 except with low dose 100 mg/kg other two doses i.e, medium 
and high have significantly reduced the ulcer number, ulcer index and the ulcer formation (30% and 
62%) is significantly reduced. Similar to the above a significant reduction in gastric volume, free and 
total acidity is noted with medium and high doses but not with the low doses of Musumusukai 
legium.  
DISCUSSION 
 In the present study, we have indicated that the Musumusukai legium has an effective 
antisecretory and anti-ulcer activity against pyloric ligation-induced gastric ulcers. The examination 
of acute toxicity (LD50) carried out on mice indicated that Musumusukai legium has no toxicity 
when administered orally (up to 5g/kg). The gastric protective effect of the Musumusukai legium 
may be related to an antacid effect or cytoprotective properties. The cytoprotective action showed 
that the effect of Musumusukai legium is not only a simple acid neutralizing activity but the 
Musumusukai legium has a cytoprotective effect against the gastric mucosa in the rats.  
 The etiology of peptic ulcer is unknown in most of the cases, yet it is generally accepted that 
it results from an imbalance between aggressive factors and the maintenance of mucosal integrity 
through the endogenous defence mechanisms. Musumusukai legium- a siddha drug used in the 
present study to evaluate the anti-ulcerogenic effect in pylorus ligation induced ulcers in rats.  
 The causes of gastric ulcer pyloric ligation are believed to be due to stress induced increase in 
gastric hydrochloric acid secretion and/or stasis of acid and the volume of secretion is also an 
important factor in the formation of ulcer due to exposure of the unprotected lumen of the stomach to 
the accumulating acid. Pylorus ligation induced ulcers are due to auto digestion of the gastric mucosa 
and breakdown of the gastric mucosal barrier. These factors are associated with the development of 
upper gastrointestinal damage including lesions, ulcers and life threatening perforation and 
hemorrhage.  
 
 
    
157 
 
CONCLUSION 
 The antiulcer property of Musumusukai legium in pylorus ligation model is evident from its 
significant reduction in free acidity, total acidity, number of ulcers and ulcer index. Musumusukai 
legium treated animals significantly inhibited the formation of ulcers in the pylorus ligated rats and 
also decreased both the concentration and increased the pH, it is suggested that Musumusukai legium 
can suppress gastric damage induced by aggressive factors. The results of the present study suggest 
that the Musumusukai legium may be beneficial in the treatment of gastric lesions. Further studies to 
identify the active moieties and elucidation of the mechanism of action are recommended. 
Table 1 — Effect of Musumusukai legium on total and free acidity, gastric volume and ulcer 
index 
Groups Total acidity 
(mEq/l) 
Free aciditly 
(mEq/l) 
Gastric Volume 
(ml/100g) 
Ulcer index  
(% Ulcer 
protection) 
Normal control 172±2.28 115.11±0.48 2.9±0.05 1.15±0.02 
Control (Pyloric ligated) 251±2.84 173.23±0.52 4.76±0.04 5.00±0.05 
Musumusukai legium 
(100mg/kg) 
232±4.12* 175.04±1.99 4.15±0.03 5.06±0.03  
Musumusukai legium 
(200mg/kg) 
163.20±4.28** 112.67±2.19** 3.22±0.04** 3.46±0.04* 
(30.08%) 
Musumusukai legium 
(400mg/kg) 
150.04±3.24** 123.35±1.44** 2.86±0.03** 1.90±0.03** 
(62%) 
Ranitidine (100mg/kg) 162±2.19** 123.08±0.53** 2.68±0.07** 1.25±0.05** 
(75%) 
 
*P values <0.05 as compared to ligation control; Values are the mean ± S.E.M. of six rats 
/treatment. Significance *p <0.05, **p<0.01 Vs Control 
 
 
 
 
    
158 
 
TOXICITY STUDIES OF MUSUMUSUKAI LEGIUM 
Administration of doses:  
 Musumusukai legium suspended in 0.5% CMC with vigourous mixing and was administered to the 
groups of mice in a single oral dose by gavage using a feeding needle. The control group received an equal 
volume of the vehicle. Animals, test conditions, Randomization, Numbering and Grouping and observations 
are similar as explained in the toxicological study of Gunmathi Chooranam.  
 
Test substance and Vehicle:  
 The test substance is freely soluble in water but the cake formation or settling was observed. 
The suspension was made with 0.5% CMC solution for dose accuracy.  
 
SUBACUTE ORAL TOXICITY STUDY OF MUSUMUSUKAI LEGIUM IN RATS 
Justification for Dose Selection: 
 The results of acute toxicity studies revealed that Musumusukai legium was non toxic upto the dose 
level of 5000 mg/kg body weight on oral drug treatment. Based on these results, the doses were selected for 
the sub acute toxicity study as 100mg/kg, 200 mg/kg and 400mg/kg body weight.  
 
Preparation and administration of dose: 
 Musumusukai legium was suspended in CMC in distilled water to obtain concentrations of 200mg/ml. 
It was administered to animals at the dose levels of 100mg/kg, 200mg/kg and 400mg/kg in the dose volume of 
10mL/kg. The test drug suspensions were freshly prepared for entire duration of study. The control animals 
were administered vehicle only.  
RESULTS: 
Clinical signs: 
Animals were healthy and active in the total duration of the study and none of the animal showed any 
significant toxic signs during the dosing period of 28 days. 
Mortality: The animals of control group and treated groups survived throughout the study. 
Body weight: The body weight of the different groups of test drug treated animals and control were gained 
gradual increase in body weight during the dosing period. 
Food consumption: The food consumption by the animals from different treated groups was found to be 
comparable and satisfactory. 
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Ophthalmoscopy: Animals of treated groups did not reveal any significant abnormality. 
Functional Observations: The experimental animals did not reveal any abnormalities.  
Urine analysis: Urine parameters of drug treated group and control found to be normal.  
Organ Weight: Organ weight of test drug treated animals was compared with control group of animals on 
day 29 was found to be normal.  
Necropsy: Pathological examination in control as well as the treated groups did not reveal any abnormalities.  
Haematological investigations: The results of haematological parameters conducted on day 29, indicated the 
slight decrease in the total RBC count in the dose group of 400 mg/kg (P<0.05). There was no other major 
alteration in heamatological parameters in drug treated group except Hb level is slightly increased in 
400mg/kg group. 
Biochemical Investigations: The results of Biochemical investigations conducted on days 29 revealed that 
the bilurubin range is modified significantly by the high dose of Musumusukkai legium. Blood Urea Nitrogen 
is slightly minimized in 400mg/kg dose group but it is not statistically significant. Aspartate Amino 
transferase levels slightly increased in animals of 400mg/kg group (P<0.05). No remarkable changes were 
identified in the other biochemical parameters in all drug treated group of animals. Rest of the values obtained 
was within normal biological and laboratory limits.  
Histopathology: Animals after 28 days exposure to Musumusukkai legium revealed no significant changes in 
the vital organs. Microscopic observation of  kidney & liver found to be normal,  Stomach section indicates no 
abnormal architecture,. Ovary of rats fed with different concentration of Musumusukkai legium for a period of 
28 days suggest no significant tissue damage and were comparable with those of normal control animals. 
DISCUSSION:  
1) All the animals were survived throughout the dosing period of 28 days. 
2) No signs of intoxication were observed from lower to higher dose treated groups in throughout the study. 
3) Animals from all the treated dose groups exhibited comparable and appreciable weight gain during the 
dosing period. 
4) Food consumption of control and treated animals was found to be satisfactory. 
5) Ophthalmoscopic examination, conducted prior to and at the end of dosing period on animals from control 
and all the treated dose groups did not reveal any abnormality. 
6) Haematological analysis conducted at the end of the dosing period on day 29, revealed no significant 
abnormalities attributable to the treatment. 
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7) Biochemical analysis conducted at the end of the dosing period on day 29, revealed no remarkable 
abnormalities attributable to the treatment. 
8) Functional observation tests conducted at termination revealed no abnormalities. 
9) In the gross examination of urine of test animals, the volume and intensity of colour is increased in dose 
dependent manner and epithelial, pus cells and oxalate crystals were present in the urine deposit of the drug 
treated animals.  
10) Histopathological and pathological examination did not reveal any major or harmful abnormality. 
CONCLUSION: 
During the experimental period, there were no treatment-related effects on the hematological 
parameters evaluated. As the macroscopic appearance and weight of the kidney was not altered, hence, the 
possibility of renal injuries could not be confirmed. Administration of Musumusukkai legium did not induced 
any changes in the biochemical parameters. This observation could indicate that liver function is preserved by 
oral administration of Musumusukkai legium. In conclusion, this study demonstrated that Musumusukkai 
legium seems to be destitute of toxic effects, which could be compromise the medicinal use of this medicine.  
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Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 5 + - - - + + - - - - - - - - - - - - - - 
2 50 + - - - + + - - - - - - - - - - - - - - 
3 300 + - - - + + - - - - - - - - + + + - +  - 
4 2000 + - - + + + - - - - - - - - + + + - + - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Decreased Motor 
Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
 
 
Table 2. Body wt (g) of albino rats exposed to Musumusukai Legium for 28days. 
Dose 
(mg/kg/day) Days 
1 7 14 21 28 
Control 141.0 ± 9.0 141.0 ± 9.0 143.0 ± 7.5 149.0 ± 7.0 170.0 ± 10.0 
100 130.0 ± 10.0 130.0 ± 10.0 127.5 ± 8.5 108.0 ± 2.0 105.0 ± 1.0 
200 133.0 ± 13.0 133.0 ± 23.0 135.0 ± 20.5 135.0 ± 20.0 133.0 ± 1.0 
400 127.5 ± 7.5 127.5 ± 7.5 132.0 ± 7.0 132.0 ± 3.0 136.5 ± 0.5 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 3. Food (g/day) intake of albino rats exposed to Musumusukai Legium for 28days. 
Dose 
(mg/kg/day) 
Days(gms/rats) 
1 7 14 21 28 
Control 39.983.18 34.512.87 39.983.18 38.122.80 38.563.10 
100 36.643.92 34.632.00 33.282.00 30.802.51 32.492.20 
200 49.373.00 46.182.12 44.192.863 44.332.17 42.143.18 
400 40.122.48 42.502.28 40.122.19 38.082.00 40.002.64 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
 
 
 
Table 4. Water (ml/day) intake of male and female albino rats exposed to Musumusukai Legium for 
28days. 
 
Dose 
(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 46.682.58 44.153.66 45.102.15 40.142.40 41.03.02 
100 48.162.89 45.193.48 42.003.76 38.681.99 40.303.78 
200 52.003.10 49.112.19 44.683.72 40.282.41 40.002.40 
400 39.462.18 42.122.40 40.692.35 39.772.66 39.312.46 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 5. Hematological parameters after 28days treatment with Musumusukai Legium in rats. 
Parameter Control 100 mg/kg 200 mg/kg 400 mg/kg 
Red blood cell 
(mm3) 
6.710.78 6.850.44 6.919.27 6.880.36 
HB (%) 15.10.66 15.180.21 15.060.32 15.060.23 
Leukocyte 
(x106/mL) 
10816.66487.51 11383990.79 11266504.65 11384845.22 
Platelets/ul 957.6675.38 935.6621.83 930.553.14 938.521.81 
MCV (gl) 68.384.53 60.486.64 60.86.14 60.315.25 
DLC (%) 
N 71.67 6.51.37 71.41 6.661.63 
L 89.661.03 90.332.16 90.161.47 90.163.06 
M 1.830.40 20.89 1.830.75 20.63 
E 10.00 10.00 1.50.54 10.00 
B 00.00 00.00 00.00 00.00 
ESR(mm) 100 10.02 1.50.04 100 
PCV 45.662.95 41.334.17 423.40 423.84 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 6. Effect of treatment with Musumusukai Legium biochemical parameters. 
LFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total Bilirubin (mg/dL) 0.2310.09 0.2330.08 0.2240.02 0.2450.05 
Bilirubin direct (mg/dL) 0.150.083 0.150.054 0.160.08 0.020.089 
Bilirubin indirect (mg/dL) 0.160.081 0.210.07 0.230.08 0.280.07 
ALP (U/L) 18963.56 23941.35 197.3356.09 206.3364.30 
SGOT (U/L) 153.3316.04 15615.38 159.3316.23 170.3311.05 
SGPT(U/L) 62.515.21 55.55.32 57.665.39 52.55.01 
Total Protein(g/dl) 7.980.47 8.060.39 8.230.37 8.080.43 
Albumin(g/dl) 3.010.26 3.160.29 3.310.27 30.35 
Globulin(g/dl) 4.960.61 4.90.56 4.930.59 4.910.46 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
 
Table-7 RFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Urea(mg/dL) 58.191.56 62.102.88 64.192.10 64.982.80 
Creatinine (mg/dL) 0.45  0.050 0.48  0.04 0.45  0.04 0.45  0.06 
Uric acid (mg/dL) 1.50.10 1.510.27 1.510.29 1.460.23 
Na m.mol 138.127.30 137.105.71 134.155.30 132.645.07 
K m.mol  21.602.84 27.831.16 28.51.87 29.161.47 
Cl m.mol 99.143.18 102.833.37 102.52.42 103.162.13 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
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Table-8. Lipid Profile 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total cholestrol(mg/dL) 41.982.78 38.073.28 38.304.22 40.663.50 
HDL(mg/dL)  12.191.65 12.61.12 13.010.27 13.001.32 
LDL(mg/dL) 32.82.88 31.992.53 40.082.90 38.352.10 
VLDL(mg/dl)  16.192.46 16.601.00 17.42.81 16.875.70 
Triglycerides (mg/dl) 82.153.38 109.6616.76 102.3319.81 108.9120.34 
TC/HDL ratio (g/dl) 3.420.21 3.460.12 3.840.26 4.100.28 
Blood glucose(mg/dl) 112.168.62 109.76.50 119.084.48 114.56.22 
Table-9 Urine Analysis 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg 
Colour Yellow Straw Yellow PaleYellow Yellow 
Transparency Clear Clear Dark High intense 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 7.2 >7.0 >7.2 
Protein Nil Nil Nil Nil 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve -ve -ve -ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Normal Normal Normal 
Pus cells 0-cells/HPF Nil 4-5cells/HPF 3-5cells/HPF 
RBCs Nil Nil Nil Nil 
Epithelial cells Nil 1-2cells/HPF 1-2cells/HPF 2-3cells/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01. vs. control group N=6. 
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Table 10. Effect of oral administration of a Musumusukai Legium on organ weight 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Liver (g)  4.480.8 4.660.7 4.960.10 4.290.11 
Heart (g) 0.560.04 0.580.03 0.530.04 0.550.04 
Lung (g) 1.280.7 1.120.9 1.300.05 1.220.04 
Spleen (g) 0.580.05 0.620.05 0.580.04 0.650.04 
Ovary (g) 2.120.10 2.00.06 2.100.06 2.00.8 
Testes (g) 1.360.12 1.330.10 1.380.8 1.360.10 
Brain (g) 1.430.12 1.460.8 1.420.05 1.460.05 
Kidney (g) 0.660.07 0.640.05 0.670.05 0.650.07 
Stomach (g) 1.330.9 1.300.10 1.290.04 1.300.12 
 
Values are mean of 6 animals  S.E.M. (Dunnett's test). *P<0.05; **P<0.01 vs control N=6. 
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OP/IP CASE SHEET PEROFORMA 
POST GRADUATE DEPARTMENT, POTHU MARUTHUVAM (BRANCH-I) 
GOVT.SIDDHA MEDICAL COLLEGE & HOSPITAL, CHENNAI-106. 
 
PROFORMA FOR ‘ERIGUNMAM’ 
    OP/IP No                             :                                         OCCUPATION: 
   WARD No                            :                                         INCOME: 
    BED No                               :                     NATIONALITY: 
     NAME                                :                                         RELIGION: 
     AGE                                    :                                         D.O.A: 
    SEX                                     :                                          D.O.D: 
    DIAGNOSIS                       : 
 
PERMANENT ADDRESS: 
                                                       
TEMPERORY ADDRESS: 
 
                                                                                                                MEDICAL OFFICER 
 
COMPLIANTS AND DURATION 
 
 
HISTORY OF PRESENT ILLNESS 
 
 
HISTORY OF PAST ILLNESS 
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PERSONAL HISTORY/ HABITS 
a. Food                                                              Veg                                                       Non Veg 
b. Marital status                                               Single                                                      Married 
c. Smoking                                                        Yes                                                          No 
d. Drinking                                                        Yes                                                          No 
FAMILY HISTORY: 
GENERAL EXAMINATION: 
Physical built:                                     Lean                         Normal                              Obese 
Consciousness: 
Body weight: 
Temperature: 
Pallor: 
Cyanosis: 
Jaundice: 
Clubbing: 
Pedal Oedema: 
Lymph adenopathy: 
Jvp: 
Pulse rate: 
Heart rate: 
Respiratory rate: 
Blood pressure: 
Examination of vital organs: 
Heart 
Lungs 
Abdominal organs 
Palpitation: 
Tenderness in epigastric region:             present                                                  absent 
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SIDDHA ASPECTS 
 
Yaakai (udalnilai)                                                                                         Mukkunam 
 
1. Vatham                                                                                                  1. Sathuva gunam 
2. Pitham                                                                                                   2. Raasatha gunam 
3. Kapham                                                                                                 3. Thamo gunam 
4. Kalappu 
 
Paruva kaalam (seasons)                                                                      Nilam (places) 
 
1. Karr (Aavani-Puratasi) Aug 16-Oct15                                              1. Kurinchi (Hill area) 
2. Koothri (Aypasi-Karthigai) Oct16-Dec15                                        2. Mullai (Forest Area) 
3. Munpani (Maargazhi-Thai) Dec16-Feb15                                        3. Marutham (Fertile Area) 
4. Pinpaani (Massi-Panguni) Feb 16-Apr15                                         4. Neithal (Sea Area) 
5. Elavenil (chithirai-Vaikasi) Apr16- Jun 15                                      5. Paalai (Desert Area) 
6. Mudhuvenil (Aani-Aadi) Jun16-Aug 15 
 
Iyamporigal/Pulangal                                                      Kanmenthiriyam/Kanmavidayam  
 
1. Mei (Sensation)                                                                                 1. Kai (Koduthal) 
2. Vaai (Taste)                                                                                       2. Kaal (Nadathal) 
3. Kann (vision)                                                                                     3. Vaai (Pesal) 
4. Mooku (Smell)                                                                                   4. Eruvai (Kazthial) 
5. Sevi (Hearing)                                                                                    5. Karuvai (Ananthithal) 
 
Mummalam 
 
Malam 
Moothiram 
Viyarvai 
 
Kosam 
1. Annamaya Kosam (paru udambu) 
(yelu udal Thaathukkal) 
2. Pranamaya Kosam (Vali udambu) 
(Pranan + Kanmenthiriyam) 
3. Manomaya Kosam (Mana udambu) 
(Manam + Gnanethiriyam) 
4. Gnanamaya Kosam (Arivu udambu) 
(Puththi + Gnanenthiriyam) 
5. Ananthamaya Kosam (Inba udambu) 
(Pranan + Suzhuthi) 
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Uyir Thathukkal: 
 Vatham: 
1. Pranan 
2. Abanan 
3. Viyanan 
4. Udhanan 
5. Samanan 
6. Naagan 
7. Koorman 
8. Kirukaran 
9. Devadathan 
10. Dhananjayan 
Pitham: 
1. Analagam 
2. Ranjagam 
3. Saadhagam 
4. Aalosagam 
5. Prasagam 
Kapham: 
1. Avalambagam 
2. Kledagam 
3. Podhagam 
4. Tharpagam 
5. Santhigam 
Udal Thathukkal: 
1. Saaram 
2. Senneer 
3. Oon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam / Suronitham 
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Envagai Thervu: 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
5. Sparisam 
6. Malam 
a)  Niram 
b)  Nurai 
c)  Erugal 
d)  Elagal 
  Moothiram 
 1. Neerkuri 
       a) Niram 
  b) Edai 
  c) Manam 
  d) Nurai 
  c) Enjal 
 2. Neikuri 
 
 Naadi 
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SIGNS AND SYMPTOMAS OF ERIGUNMAM 
 
 
Symptoms 
 
 
Before treatment 
 
After treatment 
 
I.PAIN RELATED 
TO FOOD 
 7th day 14th 
day 
21st 
day 
30th day 
A.Epigastric discomfort 
a. After meals 
b. 1 to 2 hours a. meals 
c. 2 to 4 hours a. meals 
     
B.Burning sensation in 
Epigastrium 
a.Before meals 
b. 1 to 2 hours a. meals 
c. 2 to 4 hours a. meals 
d. Contant. 
     
 
C. Site of pain 
Pain radation 
a. No radation 
b. Left shoulder 
c. Back 
d. Sides of chest. 
     
 
E. Diarrhoea 
Present 
Not present 
If present 1 to 2 hours a.m. 
2 to 4 hours a.m. 
     
F. pain relived by 
a . food 
b. antacids 
c. bed rest 
d. sidhha drugs 
e. vomiting 
f. not relived by all       
methods 
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Before treatment 
 
After treatment 
 
I. Appetite 
a. Poor 
b. Moderate 
c. Normal 
d. ferocious 
 
 
 7th day 14th 
day 
21st 
day 
30th day 
Signs :- Examination 
Of Abdomen 
     
1. Tenderness 
epigastrium 
a. Present 
b. Not present 
 
 
     
2.Headache 
a. Present 
b. Not present 
 
 
     
 
3.Rigidity of rectus 
Abdominus 
a. Present 
b. Not present 
 
     
4. Visible Gastric 
Pesistalsis 
a. Present 
b. Not present 
 
 
     
 
5. Palpable mass 
a. Present 
b. Not present 
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OTHER SIGNS AND SYMPTOMS 
  
Before treatment 
 
After treatment 
1. Constipation   
2. Bloating   
3. General debility   
4. Anorexia   
5. Giddiness   
6. Heaviness Of Head   
7. Cough   
8. Dyspnoea   
9. Urine Coloured   
10. Sweating   
11. Palpitation   
12. Emaciation   
13. Heamatemisis   
 
Laboratory investigation 
                                                                                       BT                                                AT   Blood  
           Tc 
           Dc 
           ESR 
           Hb 
           Bl sugar (R) 
           Bl sugar (F)                (PP) 
           Bl urea 
           Sr.cholesterol 
Urine  
            Alb 
            Sug 
            Dep 
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Motion  
            Ova 
            Cyst 
            Occult blood 
X ray   
            Barium meal 
Endoscopy 
USG 
Trial drug 
Dose 
Anubanum 
 
Duration of treatment 
 
Pathiam (do’s &don’ts) 
 
Prognosis at the end of the treatment 
 
 
 
Medical officer signature                                                                              
                                                                                                                           
 
 
                                                                                                                                 H O D 
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CONSENT FORM 
              I certify that I have disclosed all the details about the study of the terms readily  
Understood by the patients. 
Date:                                                                                       SIGNATURE 
 
                                                                                                 NAME 
 
CONSENT BY THE PATIENT 
                     I have been informed to my satisfaction by the attending physician the purpose  
of the clinical trial and nature of the drug treatment and follow up including the lab  
investigation to be performed to monitor and safeguard my body functions. 
                     I am aware of my right to opt out of the trail at any time during the course of the  
trail without having to give reasons for doing so. 
                     I exercising my free power of choice, here by give consent to be included as a  
subject is the clinical trial of GUNMATHI CHOORNAN and MUSUMUSUKAI  
LEGIYAM for the treatment of ERIGUNMAM 
 
 
Date:                                                                                               SIGNATURE 
 
                                                                                                         NAME 
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